Curing All Human Diseases & the Future of Health & Technology | Mark Zuckerberg & Dr. Priscilla Chan

In this episode, my guests are Mark Zuckerberg, CEO of Meta (formerly Facebook, Inc.), and his wife, Dr. Priscilla Chan, M. D., co-founder and co-CEO of the Chan Zuckerberg Initiative (CZI). We discuss how CZI plans to cure all human diseases by the end of this century by funding transformative projects and technologies at the intersection of biology, engineering, and artificial intelligence (AI). They describe their funding and development of Biohubs and the progress already underway to accelerate the understanding of cell function, pathways, and disease. Then, Mark discusses social media, its impact on mental health, and new tools for online experiences. We also discuss Meta’s virtual reality (VR), augmented and mixed reality tech, and how AI will soon completely transform our online and physical life experiences. This episode ought to interest anyone curious about biology, medicine, mental health, AI, and the future of technology and humanity. For show notes, including referenced articles and additional resources, please visit hubermanlab.com. Use Ask Huberman Lab, our new AI-powered platform, for a summary, clips, and insights from this episode. Thank you to our sponsors AG1: https://drinkag1.com/huberman LMNT: https://drinklmnt.com/hubermanlab Waking Up: https://wakingup.com/huberman Momentous: https://livemomentous.com/huberman Timestamps (00:00:00) Mark Zuckerberg & Dr. Priscilla Chan (00:02:31) Sponsors: LMNT & Waking Up (00:05:35) Chan Zuckerberg Initiative (CZI) & Human Disease Research (00:08:51) Innovation & Discovery, Science & Engineering (00:12:53) Funding, Building Tools & Imaging (00:17:57) Healthy vs. Diseased Cells, Human Cell Atlas & AI, Virtual Cells (00:21:59) Single Cell Methods & Disease; CELLxGENE Tool (00:26:30) Sponsor: AG1 (00:29:53) AI & Hypothesis Generation; Long-term Projects & Collaboration (00:35:14) Large Language Models (LLMs), In Silico Experiments (00:42:11) CZI Biohubs, Chicago, New York (00:50:52) Universities & Biohubs; Therapeutics & Rare Diseases (00:57:23) Optimism; Children & Families (01:07:25) Technology & Health, Positive & Negative Interactions (01:13:17) Algorithms, Clickbait News, Individual Experience (01:19:17) Parental Controls, Meta Social Media Tools & Tailoring Experience (01:24:51) Time, Usage & Technology, Parental Tools (01:28:55) Virtual Reality (VR), Mixed Reality Experiences & Smart Glasses (01:36:09) Physical Exercise & Virtual Product Development (01:44:19) Virtual Futures for Creativity & Social Interactions (01:49:31) Ray-Ban Meta Smart Glasses: Potential, Privacy & Risks (02:00:20) Visual System & Smart Glasses, Augmented Reality (02:06:42) AI Assistants & Creators, Identity Protection (02:13:26) Zero-Cost Support, Spotify & Apple Reviews, Sponsors, YouTube Feedback, Momentous, Social Media, Neural Network Newsletter Disclaimer Learn more about your ad choices. Visit megaphone.fm/adchoices

Speaker names marked ? are inferred from speaking time and the show’s known hosts — they are not voice-verified.

• 0:00Andrew D. Huberman?

  Welcome to the Huberman Lab Podcast where we discuss science and science-based tools for everyday life.

• 0:09Andrew D. Huberman?

  I'm Andrew Huberman and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine. My guests today are Mark Zuckerberg and Dr. Priscilla Chan. Mark Zuckerberg, as everybody knows, founded the company Facebook. He is now the CEO of Meta, which includes Facebook, Instagram, WhatsApp, and other technology platforms. Dr. Priscilla Chan graduated from Harvard and went on to do her medical degree at the University of California, San Francisco. Mark Zuckerberg and Dr. Priscilla Chan are married and the co-founders of the CZI, or Chan Zuckerberg Initiative, a philanthropic organization whose stated goal is to cure all human diseases. The Chan Zuckerberg Initiative is accomplishing that by providing critical funding not available

• 0:53Andrew D. Huberman?

  elsewhere, as well as a novel framework for discovery of the basic functioning of cells, cataloging all the different human cell types, as well as providing AI, or artificial intelligence, platforms to mine all of that data to discover new pathways and cures for all human diseases. The first hour of today's discussion is held with both Dr. Priscilla Chan and Mark Zuckerberg, during which we discuss the CZI and what it really means to try and cure all human diseases. We talk about the motivational backbone for the CZI that extends well into each of their personal histories. Indeed, you'll learn quite a lot about Dr. Priscilla Chan, who has, I must say, an absolutely incredible family story, leading up to her role as a physician and her motivations for the CZI and beyond.

• 1:38Andrew D. Huberman?

  And you'll learn from Mark how he's bringing an engineering and AI perspective to discovery of new cures for human disease. The second half of today's discussion is just between Mark Zuckerberg and me, during which we discuss various meta-platforms, including, of course, social media platforms, and their effects on mental health in children and adults. We also discuss VR, virtual reality, as well as augmented and mixed reality. And we discuss AI, artificial intelligence, and how it stands to transform not just our online experiences with social media and other technologies, but how it stands to potentially transform every aspect of everyday life. Before we begin, I'd like to emphasize that this podcast is separate from my teaching and research roles at Stanford. It is, however, part of my desire and effort to bring zero

• 2:23Andrew D. Huberman?

  cost to consumer information about science and science-related tools to the general public. In keeping with that theme, I'd like to thank the sponsors of today's podcast.

• 2:31Speaker 01

  Mr. President, my company for me of the explosion on our rig on October 2nd. Causing massive water displacement and triggering a tsunami. They all heap the blame on me. Tom Cruise is.

• 2:42Speaker 02

  Digger got us into this mess and Digger's gonna dig us up. From the director of Birdman and the Revenant.

• 2:48Speaker 03

  What would happen if I stopped drilling? You start, you freeze to death, that's what.

• 2:52Speaker 02

  With great power comes great deniability.

• 2:55Speaker 03

  I'm not the first then.

• 2:56Speaker 02

  Digger. See the trailer online. Only in theaters October 2nd. Rated R. Under 17 not admitted without parent.

• 3:04Speaker 04

  Every mile matters. Whether you're driving your dream car or your daily commuter, the Mobile One team knows that. It's why we created Mobile One Advanced Clean Motor Oil. It cleans your engine in one oil change and helps extend engine life, delivering performance, protection, and cleanliness for vehicles of all ages. All to help keep your engine running like new. Whatever you're driving. Visit mobileone.com/advancedclean to learn more.

• 3:32Andrew D. Huberman?

  And now for my discussion with Mark Zuckerberg and Dr. Priscilla Chan. Priscilla, Mark, so great to meet you and thank you for having me here in your home.

• 3:40Speaker 05

  Thanks for having us on the podcast.

• 3:41Speaker 03

  Yeah.

• 3:43Andrew D. Huberman?

  I'd like to talk about the CZI, the Chan Zuckerberg Initiative. I learned about this a few years ago when my lab was and still is now at Stanford as a very exciting, philanthropic effort that has a truly big mission. I can't imagine a bigger mission. So maybe you could tell us what that big mission is and then we can get into some of the mechanics of how that big mission can become a reality.

• 4:09Speaker 06

  So like you're mentioning, in 2015, we launched the Chan Zuckerberg Initiative. And what we were hoping to do at CZI was think about how do we build a better future for everyone? And looking for ways where we can contribute the resources that we have to bring philanthropically, and the experiences that Mark and I have had, for me as a physician and educator, for Mark as an engineer, and then our ability to bring teams together to build builders. You know, Mark has been a builder throughout his career, and what could we do if we actually put together a team to build tools, do great science?

• 4:51Speaker 06

  And so, within our science portfolio, we've really been focused on what some people think is either an incredibly audacious goal, or an inevitable goal, but I think about it as something that will happen if we sort of continue focusing on it, which is to be able to cure, prevent, or manage all disease by the end of the century.

• 5:11Andrew D. Huberman?

  All disease.

• 5:12Speaker 06

  All disease. So that's important, right? And a lot of times, people ask, like, which disease? And the whole point is that there is not one disease. And it's really about taking a step back to where I always found the most hope as a physician, which is new discoveries, and new opportunities, and new ways of understanding how to keep people well, come from basic science. So our strategy at CZI is really to build tools, fund science, change the way basic scientists can see the world, and how they can move quickly in their discoveries. And so, that's what we launched in 2015. We do work in three ways.

• 5:56Speaker 06

  We fund great scientists. We build tools, right now, software tools, to help move science along, and make it easier for scientists to do their work. And we do science. You mentioned Stanford being an important pillar for our science work. We've built what we call biohubs, institutes where teams can take on grand challenges, to do work that wouldn't be possible in a single lab, or within a single discipline. And our first biohub was launched in San Francisco, a collaboration between Stanford, UC Berkeley, and UCSF.

• 6:36Andrew D. Huberman?

  Amazing. Curing all diseases implies that there will either be a ton of knowledge gleaned from this effort, which I'm certain there will be, and there already has been. We can talk about some of those early successes in a moment. But it also sort of implies that if we can understand some basic operations of diseases and cells that transcend autism, Huntington's, Parkinson's, cancer, and any other disease, that perhaps there are some core principles that would make the big mission a real reality, so to speak. What I'm basically saying is, how are you attacking this? My belief is that the cell sits at the center

• 7:21Andrew D. Huberman?

  of all discussion about disease, given that our body is made up of cells and different types of cells. So maybe you could just illuminate for us a little bit of what the cell is in your mind as it relates to disease, and how one goes about understanding disease in the context of cells, because ultimately, that's what we're made up of.

• 7:42Speaker 05

  Yeah, well, let's get to the cell thing in a moment, but just even taking a step back from that. You know, we don't think that it's easy that we're going to cure, prevent, or manage all diseases. The goal is to basically give the scientific community and scientists around the world the tools to accelerate the pace of science. And we spent a lot of time when we were getting started with this, looking at the history of science and trying to understand the trends and how they've played out over time. And if you look over this very long-term arc, most large-scale discoveries are preceded by the invention of a new tool or a new way to see something. And it's not just in biology, right? It's like having a telescope, you know, came before a lot of discoveries in astronomy

• 8:25Speaker 05

  and astrophysics. But similarly, you know, the microscope and just different ways to observe things, or different platforms, like the ability to do vaccines preceded the ability to kind of cure a lot of different things. So this is sort of the engineering part that you were talking about, about building tools. We view our goal is to Try to bring together some scientific and engineering knowledge to build tools that empower the whole field. And that's that's sort of the big arc and a lot of the things that we're focused on, including the the work in in single cell and cell understanding, which you can you can jump in and get into that if you want. But yeah, I think I think we generally agree with the premise

• 9:07Speaker 05

  that if you want to understand this stuff from first principles, people study organs a lot, right? They like to study kind of how things present across the body. But there's not a very widespread understanding of how kind of each cell operates. And this is sort of a big part of, you know, some of the initial work that we tried to do on the Human Cell Atlas and understanding what are the different cells. And there's there's a bunch more work that we want to do to carry that forward. But but overall, I think when we think about the next 10 years here of this long arc to try to empower the community to to be able to cure, prevent, or manage all diseases, we want that we think that the next 10 years should really be primarily about being able to measure and observe more things in human biology. There are a lot of

• 9:52Speaker 05

  limits to that. It's like you want to look at something through a microscope. You can't usually see living tissues because it's hard to, you know, see through skin or things like that. So there there are a lot of different techniques that will help us observe different things. And this is sort of where the engineering background comes in a bit, because I mean, it's when I think about this is from the perspective of like how you'd write code or something, you know, the idea of like trying to debug or fix a code base, but not be able to like step through the code line by line. It's like not going to happen. Right. And at the at the beginning of any big project that we do at Meta, you know, we like to spend a bunch of the time up front just trying to instrument things and understand, you know, what are we going to look at and how are we going to measure things before so we know we're making progress and know what to optimize. And this is such a

• 10:36Speaker 05

  long term journey that we think that it actually makes sense to take the next 10 years to build those kind of tools for biology and understanding just how the human body works in action. And a big part of that is cells. I don't know. Do you want to jump and talk and talk about some of the efforts?

• 10:53Andrew D. Huberman?

  Could I just interrupt briefly and just ask about the the different? The different interventions, so to speak, that CZI is in a unique position to bring to the quest to cure all diseases. So I can think of, I mean, I know as a scientist that money is necessary, but not sufficient. Right? Like when you have money, you can hire more people, you can try different things. So that's critical, but a lot of philanthropy includes money.

• 11:22Andrew D. Huberman?

  The other component is, you know, you want to be able to see things, as you pointed out. So you want to know the normal disease process, like what is a healthy cell? What's a diseased cell? Are cells constantly being bombarded with with challenges and then repairing those? And then what we call cancer is just kind of runaway train of those challenges not being met by the cell itself or something like that. So better imaging tools. And then it sounds like there's not just a hardware component, but a software component. This is where AI comes in. So maybe we can, at some point, we can break this up into three different avenues. One is understanding disease processes and healthy processes will lump those together.

• 11:59Andrew D. Huberman?

  Then there's hardware, so microscopes, lenses, digital deconvolution, ways of seeing things in bolder relief and more more more precision. And then there's how to manage all the data. And then I love the idea that maybe AI could do what human brains can't do alone. They manage understanding of the data because it's one thing to organize data. It's another to say, oh, you know, you know, this, as you point out in the analogy with code, that this particular gene and that particular gene are potentially interesting, whereas a human being would never make that potential connection.

• 12:33Speaker 06

  So, you know, the tools that CZI can bring to the table, we we fund science like you're talking about. And we try to, there's lots of ways to fund science. And just to be clear, you know, what we fund is a tiny fraction of what the NIH funds, for instance.

• 12:50Andrew D. Huberman?

  So you guys have been generous enough that it's, it definitely holds weight to NIH. NIH's contribution.

• 12:58Speaker 06

  Yeah, and but I think it's every every funder has its own role in the ecosystem. And for us, it's really how do we incentivize new points of view? How do we incentivize collaboration? How do we incentivize open science? And so a lot of our grants include inviting people to look in, look at different fields. Our first neuroscience RFA was aimed towards incentivizing people from different backgrounds, immunologists, microbiologists, to come and look at how our nervous system works and how to keep it healthy. Or we ask that our grantees participate in the preprint movement to accelerate the rate of sharing knowledge and actually others being able to build upon science.

• 13:42Speaker 06

  So that's the funding that we do. In terms of building, we we build software and hardware, like you mentioned. We put together teams that can build tools that are more durable and scalable than someone in a single lab might be incentivized to do. There's a ton of great ideas and nowadays, most scientists can tinker and build something useful for their lab. But it's really hard for them to be able to share that tool sometimes beyond their own laptop or forget, you know, the next lab over or across the globe. So we partner with scientists to see like, what is useful?

• 14:23Speaker 06

  What kinds of tools, you know, in imaging, Nepari, like it's there's it's a useful image annotation tool that is born from an open source community. And how can we contribute to that? Or a cell by gene, which works on single cell data sets. And how can we make it build a useful tool so that scientists can share data sets, analyze their own, and contribute to a larger corpus of information? So we have software teams that are building, collaborating with scientists to make sure that we're building easy to use, durable, translatable tools across the scientific community in the areas that we work in.

• 15:04Speaker 06

  We also have institutes. This is where the imaging work comes in where, you know, we are proud owners of electron microscope right now. It's going to be installed at our imaging institute and that will really contribute to a way where we can see work differently. But we can, the more hardware need, does need to be developed. You know, we're partnering with a fantastic scientist in the Biohub network to build a mini phase plate to increase, to align the electrons through these, through the electron microscope to be able to increase the resolution so we can see in sharper detail.

• 15:48Speaker 06

  So there's a lot of innovative work within the network that's happening. And these institutes have grand challenges that they're working on. Back to your question about cells, cells are just the smallest unit that are alive. And are your body, every, all of our bodies have many, many, many cells. There's, you know, some estimate of like 37 trillion cells, different cells in your body. And what are they all doing? And how, what do they look like when they're healthy, when you're healthy? What do they look like when you're sick? And where we're at right now with, you know, our understanding of cells and what happens

• 16:30Speaker 06

  when you get sick is basically we have, we, we've gotten pretty good at, from the Human Genome Project, looking at how different mutations in your genetic code lead for you to be more susceptible to get sick or directly cause you to get sick. So we go from a mutation in your DNA to wow, you now have Huntington's disease, for instance. And there's a lot that happens in the middle. And that's one of the questions that we're going after at, at CZI is what actually happens? So an analogy that I used, I like to use to share with my friends is, right now, say we have a recipe for a cake. We know there's a typo in the recipe. And then the cake is awful.

• 17:15Speaker 06

  That's all we know. We don't know how the chef interprets the typo. We don't know what happens in the oven. And we don't actually have know sort of how it's exactly connected to how the cake didn't turn out, how you had expected. A lot of that is unknown, but we can actually systematically try to break this down. And one segment of that journey that we're looking at is how that mutation gets translated and acted upon in your cells. And all of your cells have what's called mRNA. mRNA are the actual instructions that are taken from the DNA. And what our work in single cell is, looking at how, how every cell in your body

• 18:00Speaker 06

  is actually interpreting your DNA slightly differently. And what happens when healthy cells are interpreting the DNA instructions? And when sick cells are interpreting those directions? And that is a ton of data. I just told you there's 37 trillion cells. There's different, uh, large sets of mRNA in each cell. But the work that we've been funding is looking at how, first of all, gathering that information. Um, we've been incredibly lucky to be part of a very fast-moving um, field where we've gone from in 2017, funding some methods work,

• 18:41Speaker 06

  to now having really not complete, but nearly complete atlases of how the human body works, how flies work, how mice work, uh, at the single cell level. And being able to then try to piece together, like, how does that all come together and when you're healthy and when you're sick? And the neat thing about the sort of inflection point where we're at in AI is that

• 19:08Speaker 06

  I can't look at this data and make sense of it. There's just too much of it. And biology is complex. Human bodies are complex. We need this much information. But the use of large language models can help us actually look at that data and gain insights. Look at what trends are consistent with health and what trends are unsuspected. And eventually, our hope through the use of these data sets that we've helped curate and the application of large language models is to be able to formulate a virtual cell, a cell that's completely built off of the data sets of what we know about the human body,

• 19:51Speaker 06

  but allows us to manipulate and learn faster and try new things to help move science and then medicine along.

• 20:00Andrew D. Huberman?

  Do you think we've catalogued the total number of different cell types? You know, every week I look at great journals like Cell, Nature and Science. And for instance, I saw recently that using single cell sequencing, they've categorized 18 plus different types of fat cells. We always think of like a fat cell versus a muscle cell. So now you've got 18 types. Each one is going to express many, many different genes and RNAs, MRNAs. And perhaps the one of them is responsible for, you know, what we see in the, you know, advanced type 2 diabetes or in other forms of obesity or where people can't lay down fat cells, which turns out to be just as detrimental in those extreme cases. So now you've got all these lists of genes.

• 20:45Andrew D. Huberman?

  But I always thought of single cell sequencing as necessary, but not sufficient. But you need the information, but it doesn't resolve the problem. And I think of it more of a, as a hypothesis generating experiment. Like, okay, so you have all these genes and you could say, wow, this gene is particularly elevated in the diabetics cell type of, let's say, one of these fat cells or muscle cells for that matter, whereas it's not in non-diabetics. So then of the millions of different cells, maybe only five of them differ dramatically. So then you generate a hypothesis. Oh, it's the ones that differ dramatically that are important. But maybe one of those genes.

• 21:25Andrew D. Huberman?

  When it's only, you know, 50% changed has a huge effect because of some network biology effect. And so I guess what I'm trying to get to here is, you know, how does one meet that challenge? And can AI help resolve that challenge by essentially placing those lists of genes into a, you know, 10,000 hypotheses? Because I'll tell you that the graduate students and postdocs in my lab get a chance to test one hypothesis at a time.

• 21:50Speaker 06

  I know.

• 21:50Andrew D. Huberman?

  And that's really the challenge, let alone one lab. And so for those that are listening to this, and you know, hopefully it's not getting outside the scope of of kind of like standard understanding or the understanding we've generated here. But what I'm basically saying is you have to pick at some point. More data always sounds great. But then how do you decide what to test?

• 22:08Speaker 06

  So, no, we don't know all the cell types. I think one of the one thing that was really exciting when we first launched this work was, you know, cystic fibrosis. Like cystic fibrosis is caused by mutation in C F T R. That's pretty well known. It affects a certain channel that makes it hard for mucus to be cleared. That's the basics of cystic fibrosis. When I went to medical school, it was taught as fact.

• 22:31Andrew D. Huberman?

  So their lungs fill up with fluid. These are people carrying around sacks of fluid filling up. I've known people I've worked with people like that and they have to literally dump the fluid out.

• 22:39Speaker 06

  Exactly.

• 22:40Andrew D. Huberman?

  They can't run or do intense exercise. Life is shorter.

• 22:43Speaker 06

  Life is shorter.

• 22:43Andrew D. Huberman?

  Yeah.

• 22:44Speaker 06

  And when we applied single cell methodologies to the lungs, they discovered an entirely new cell type that actually is affected by a mutation in the CF mutation and cystic fibrosis mutation that actually changes the paradigm of how we think about cystic fibrosis.

• 23:01Andrew D. Huberman?

  Amazing.

• 23:02Speaker 06

  Just enough. So I don't think we know all the cell types. I think we'll continue to discover them and we'll continue to discover new relationships between cell and disease. Which leads me to the second example I want to bring up is this large data set that the entire scientific community has built around single cell is starting to allow us to say, This mutation, where is it expressed? What types of cell types it's expressed in? And we actually have built a tool at CZI called Cell by Gene, where you can put in the mutation that you're interested in. And it gives you a heat map of cross cell types, of which cell types are expressing the gene that you're interested in.

• 23:46Speaker 06

  And so then you can start looking at, okay, if I look at gene X and I know it's related to heart disease, but if you look at the heat map, it's also spiking in the pancreas. That allows you to generate a hypothesis. Why? And what happens when this gene is mutated in the function of your pancreas? Really exciting way to look and ask questions differently. And you can also imagine a world where if you're trying to develop a therapy, a drug, and the goal is to treat the function of the heart, but you know that it's also really active in the pancreas again. So is there going to be an unexpected side effect

• 24:29Speaker 06

  that you should think about as you're bringing this drug to clinical trials? So it's an incredibly exciting tool and one that's only going to get better as we get more and more sophisticated ways to analyze the data.

• 24:43Andrew D. Huberman?

  I must say, I love that because if I look at the advances in neuroscience over the last 15 years, most of them didn't necessarily come from looking at the nervous system. Came from the understanding that the immune system impacts the brain. Everyone prior to that talked about the brain as an immune-privileged organ. What you just said also bridges the divide between single cells, organs, and systems, right? Because ultimately, cells make up organs, organs make up systems, and they're all talking to one another. And everyone nowadays is familiar with like gut-brain axis or the microbiome being so important, but rarely is the discussion between organs discussed, so to speak. So I think it's wonderful. So that tool was generated by CZI or CZI funded that tool?

• 25:28Speaker 05

  No, we built that.

• 25:29Speaker 06

  We built it.

• 25:30Andrew D. Huberman?

  You built it. So is it built by Meta? Is Meta out of hand?

• 25:33Speaker 05

  No, no, no. CZI has its own engineers.

• 25:34Andrew D. Huberman?

  Got it.

• 25:35Speaker 05

  Yeah. They're completely different organizations.

• 25:38Andrew D. Huberman?

  Incredible. And so a graduate student or postdoc who's interested in a particular mutation could put this mutation into this database. That graduate student or postdoc might be in a laboratory known for working on heart, but suddenly find that they're collaborating with other scientists that work on the pancreas.

• 25:54Speaker 06

  Yeah.

• 25:55Andrew D. Huberman?

  Which also is wonderful, because it bridges the divide between these fields. Fields are so siloed in science. Not just different buildings, but they, people rarely talk, unless things like this are happening.

• 26:04Speaker 06

  I mean, the graduate student is someone that we want to empower, because, one, they're the future of science, as you know. And within Cell by Gene, if you put in the gene you're interested in, and it shows you the heat map, we also will pull up like the most relevant papers to that gene. And so like, read these things.

• 26:21Andrew D. Huberman?

  Fantastic.

• 26:22Speaker 01

  Mr. President, my company told me of the explosion on our rig on October 2nd. Causing massive water displacement and triggering a tsunami. They all heap the blame on me. Tom Cruise is.

• 26:33Speaker 02

  Digger got us into this mess, and Digger's gonna dig us up. From the director of Birdman and the revenant.

• 26:39Speaker 03

  What would happen if I stopped going? You stop, you freeze to death, that's what.

• 26:43Speaker 02

  With great power comes great deniability.

• 26:46Speaker 03

  I'm not the first then.

• 26:47Speaker 02

  Digger. See the trailer online. Only in theaters October 2nd. Rated R. Under 17 out of 10 without parent.

• 26:52Speaker 05

  I just think, going back to your question from before, I mean, are there going to be more cell types that get discovered? I mean, I assume so, right? I mean, no catalog of the stuff is ever, you know, it doesn't seem like we're ever done, right? We keep on finding more. But I think that that gets to one of the things that I think are the strengths of, of modern LLMs, is the ability to kind of imagine different states that things can be in. So from all the work that we've done and funded on the, on the Human Cell Atlas, there is a large corpus of data that you can now train a kind of large-scale model on. And one of the things that we're doing at CCI, which I think is pretty exciting,

• 27:33Speaker 05

  is building what we think is one of the largest nonprofit life sciences AI clusters, right? It's like a, you know, on the order of 1,000 GPUs. And, you know, it's larger than what most people have access to in academia, that you can do like serious engineering work on. And And you know, by basically training a model with all of the human cell atlas data and a bunch of other inputs as well, we think you'll be able to basically imagine all of the different types of cells and all the different states that they can be in and when they're healthy and diseased and how they'll interact with, you know, different, you know, interact with each other, interact with different potential drugs.

• 28:17Speaker 05

  But I mean, I think the state of L L M's, I think this is where it's helpful to understand, you know, have a good understanding and be grounded in like the modern state of AI. I mean, these things are not foolproof, right? I mean, one of the flaws of modern L L M's is they hallucinate, right? So the question is, how do you make it so that that can be an advantage rather than a disadvantage? And I think the way that it ends up being an advantage is when they help you imagine a bunch of states that someone could be in, but then you, you know, as the scientist or engineer, go and validate that those are true, whether they're, you know, solutions to how a protein can be folded or possible states that a cell could be in when it's interacting with other things. But, you know, we're not yet at the state with AI that you can just take the outputs of these things as like as gospel and run from there.

• 29:02Speaker 05

  But they are very good, I think, as you said, hypothesis generators or possible solution generators that then you can go validate. So I think that's a very powerful thing that we can basically, you know, building on the first five years of science work around the human cell atlas and all the data that's been built out, carry that forward into something that I think is going to be a very novel tool going forward. And that's the type of thing that I think we're set up to do well. I mean, you all, you had this exchange a little while back about, you know, funding levels and how C Z I is, you know, just sort of a drop in the, in the, in the bucket compared to NIH. But I think we have this, the thing that I think we can do that's different is funding

• 29:46Speaker 05

  some of these longer term, bigger projects that it is hard to galvanize the, and pull together the energy to do that. And it's a lot of what most science funding is, is like relatively small projects that are exploring things over relatively short time horizons. And one of the things that we try to do is, is like build these tools over, you know, five, 10, 15 year periods. They're often projects that require, you know, hundreds of millions of dollars of funding and world-class engineering teams and infrastructure to do. And that I think is a pretty cool contribution to the field that, that I think is. There aren't as many other folks who are doing that kind of thing. But that's one of the reasons why I'm personally excited about the virtual cell stuff.

• 30:27Speaker 05

  Because it's like this perfect intersection of all the stuff that we've done in single cell, the previous collaborations that we've done with the field and bringing together the industry and AI expertise around this.

• 30:40Andrew D. Huberman?

  Yeah, I completely agree that the model of science that you're putting together with CZI isn't just unique from NIH, but it's extremely important. The independent investigator model is what's driven the progression of science in this country and to some extent in Northern Europe for the last 100 years. And it's wonderful on the one hand, because it allows for that image we have of a scientist kind of tinkering away or the people in their lab and then the euricas. And that hopefully translates to better human health. But I think, in my opinion, we've moved past that model as the most effective model or the only model that should be explored.

• 31:24Speaker 05

  Yeah, I just think it's a balance. I mean, I think you want that, but you want to empower those people. I think that that's, these tools empower those folks.

• 31:29Andrew D. Huberman?

  Sure, and there are mechanisms to do that like NIH. But it's hard to do collaborative sciences. It's sort of interesting that we're sitting here not far, because I grew up right near here as well, not far from the garage model of tech, right? The Hewlett Packard model, not far from here at all. And the idea was, you know, the tinkerer in the garage, the inventor. And then people often forget that to implement all the technologies they discovered took enormous factories and warehouses. So, you know, there's a similarity there to Facebook, Meta, et cetera. But I think in science, we imagine that the scientists alone in their laboratory and those eureka moments. But I think nowadays that the big questions really require extensive collaboration and certainly tool development.

• 32:13Andrew D. Huberman?

  And one of the tools that you keep coming back to is these LLMs, these large language models. And maybe you could just elaborate for those that aren't familiar. You know, what is a large language model? For the uninformed, what is it? And what does it allow? What does it allow us to do that, you know, different types of, other types of AI don't allow? Or more importantly perhaps, what does it allow us to do that a bunch of really smart people, highly informed in a given area of science, staring at the data? What can it do that they can't do?

• 32:46Speaker 05

  Sure. So I think a lot of the progression of machine learning has been about building systems, neural networks or otherwise, that can basically make sense and find patterns in larger and larger amounts of data. And there was a breakthrough a number of years back that some folks at Google actually made called this transformer model architecture. And it was this huge breakthrough because before then, there was somewhat of a cap where, you know, if you fed more data into a neural network past some, some point, it didn't really glean more insights from it. Whereas transformers just, you know, we haven't seen the end of how big that can scale to yet. I mean, I think that there's

• 33:29Speaker 05

  a chance that we run into some, some ceiling, but So it never asymptotes? We haven't observed it yet, but we just haven't built big enough systems yet. So I would guess that, I don't know, I think that this is actually one of the big questions in, in the AI field today is basically, are transformers and are the current model architectures sufficient? And if you just build larger and larger clusters, do you eventually get something that's like human intelligence or superintelligence? Or is there some kind of fundamental limit to this architecture that we just haven't reached yet? And once we, we kind of get a little bit further in building them out, then we'll reach that and then we'll need a few more leaps before we get to, you know, the, the level of, of AI that I think will unlock, you know, a ton of really futuristic and amazing

• 34:13Speaker 05

  things. But there's no doubt that even just being able to process the amount of data that we can now with this model architecture has unlocked a lot of new use cases. And the reason why they're called large language models is because one of the first uses of them is people basically feed in all of the language from basically the world wide web. And you can think about them as basically prediction machines. So if you, you, you fit in, you put in a prompt and it can basically, you know, predict a version of what should come next. So, you know, you, you like type in a headline for a news story and it can kind of predict what it thinks the story should be. Or you could train it so that

• 34:55Speaker 05

  it could be a chatbot, right? Where, okay, if, if you're prompted with this question, you can get this response. But one of the interesting things is it turns out that there's actually nothing specific to using human language in it. So if instead of feeding it human language, if you use that model architecture for a network and instead you feed it all of the human cell atlas data, then if you prompt it with a state of a cell, it can spit out different versions of like what, you know, how that cell can interact or different states that the cell could be next when it interacts with different things.

• 35:30Andrew D. Huberman?

  Does it have to take a genetics class? So for instance, if you give it a bunch of genetics data, do you have to say, hey, by the way, and then you give it a genetics class so it understands that, you know, you've got DNA, RNA, mRNA and proteins?

• 35:41Speaker 05

  No, I think that the basic, the basic nature of all these machine learning techniques is they're, they're basically pattern recognition systems. So they're these like very deep statistical machines that are very efficient at finding patterns. So it's, it's not actually, I mean, you don't need to teach a language model that's trying to, you know, speak a language, you know, a lot of specific things about that language either. You just feed it in a bunch of examples. And then, you know, let's say you teach it about something in English, but then you also give it a bunch of examples of people speaking Italian. It'll actually be able to explain the thing that it learned in English and Italian, right?

• 36:22Speaker 05

  Even though it is, so the crossover and just the pattern recognition is the thing that is pretty profound and powerful about this. But it really does apply to a lot of different things. Another example in the scientific community has been the work that AlphaFold, you know, that basically the, the folks at DeepMinds have done on, on protein folding. It's, you know, just basically a lot of the, the same model architecture, but instead of language there, they folded, they kind of fed in all of these, the protein data and you can give it a state and it can spit out solutions to how those proteins get folded. So it's very powerful. I don't think we know yet as an industry, what the,

• 37:05Speaker 05

  what the natural limits of it are. And that that's one of the things that's pretty exciting about the current state. But it certainly allows you to solve problems that just weren't solved with the generation of machine learning that came before it.

• 37:21Andrew D. Huberman?

  It sounds like CZI is moving a lot of work that was just done in vitro in dishes and in vivo in living organisms, model organisms or humans, to in silico, as we say. So do you foresee a future where a lot of biomedical research, certainly the work of CZI included, is done by machines? I mean, obviously, it's much lower cost and you can run millions of experiments, which of course is not to say that humans are not going to be involved. But I love the idea that we can run experiments in silico en masse.

• 37:57Speaker 06

  I think the in-silico experiments are going to be incredibly helpful to test things quickly, to cheaply, and to just unleash a lot of creativity. I do think you need to be very careful about making sure it still translates and matches the humans. You know, one thing that's funny in basic science is we've basically cured every single disease in mice. Like, mice have, we know what's going on when they have a number of diseases because they're used as a model organism. But they are not humans, and a lot of times, that research is relevant but not directly one-to-one translatable to humans.

• 38:42Speaker 06

  So you just have to be really careful about making sure that it actually works for humans.

• 38:47Andrew D. Huberman?

  It sounds like what CZI is doing is actually creating a new field. As I'm hearing all of this, I'm thinking, okay, this transcends immunology department, cardiothoracic surgery, neuroscience. The idea of a new field where you certainly embrace the realities of universities and laboratories, because that's where most of the work that you're funding is done, is that right? So maybe we need to think about what it means to do science differently. And I think that's one of the things that's most exciting. Along those lines, it seems that bringing together a lot of different types of people, different major institutions.

• 39:27Andrew D. Huberman?

  Is this going to be especially important? So I know that the initial CCI Biohub gratefully included Stanford. We'll put that first in the list, but also UCSF.

• 39:38Speaker 06

  Yep.

• 39:38Andrew D. Huberman?

  Forgive me, many friends at UCSF and also Berkeley. But there are now some additional institutions involved. So maybe you could talk about that and what motivated the decision to branch outside the Bay Area? And, and why you selected those particular additional institutions to be included?

• 39:57Speaker 05

  Well, I mean, I'll, I'll just say part of, a big part of why we wanted to create additional Biohubs is we were just so impressed by the work that the folks who are running the first Biohub did.

• 40:06Speaker 06

  Yeah.

• 40:07Speaker 05

  And I also think, and you should walk through the, the work of the Chicago Biohub and the New York Biohub that we just announced. But I think it's actually an interesting set of examples that balance the limits of what you want to do with like physical material engineering and, and, and where things are purely biological. Because the Chicago team is really building more sensors to be able to understand what's going on in your body. But that's more of like a physical kind of engineering challenge. Whereas the, the New York team, we basically talk about this as like a cellular endoscope of being able to have like an immune cell or something that can go and understand, you know, what is like, what's the thing that's going on in your body? But it's not like a physical piece of hardware.

• 40:52Speaker 05

  It's a cell that you can basically, you know, have, have just go report out on, on, on different things that are happening inside the body.

• 41:00Andrew D. Huberman?

  So making the cell the microscope.

• 41:02Speaker 06

  Totally.

• 41:03Speaker 05

  Yeah, and then, and then eventually actually being able to act on it. But I mean, but you should, you should go into more detail on all this.

• 41:07Speaker 06

  So a core principle of how we think about Biohubs is that it has to be, when we invited proposals, it has to be at least three institutions. So really breaking down the barrier of a single university, oftentimes asking for the people designing the research aim to come from all different backgrounds. And to explain why that the problem that they want to solve. Requires interdisciplinary, inter-university, institution collaboration to actually make happen. We just put that request for proposal out there with our San Francisco Biohub as an example, where they've done incredible work in single-cell biology and infectious

• 41:51Speaker 06

  disease. And we got, I want to say like 57 proposals from over 150 institutions. A lot of ideas came together. And, you know, we are so, so excited that we've been able to launch Chicago and New York. Chicago is a collaboration between UIUC, University of Illinois, Irana Champagne, and University of Chicago and Northwestern. If I, obviously, these universities are multifaceted, but if I were to sort of describe them by their, like, stereotypical strength, Northwestern has an incredible medical system and hospital

• 42:30Speaker 06

  system. University of Chicago brings to the table incredible basic science strengths. University of Illinois is a computing powerhouse. And so they came together and proposed that they were going to start thinking about cells and tissue. So that, one of the, one of the layers that you just alluded to. So how do the cells that we know behave and act differently when they come together as a tissue? And the fir-, one of the first tissues that they're starting with is skin. So they've been, already been able to, as a collaboration under the leadership of Shana Kelly, design art, engineered skin tissue. The architecture looks the same

• 43:14Speaker 06

  as what's in you and I. And what they've done is built these super, super thin sensors. And they embed these sensors throughout the layers of this engineered tissue. And they read out the data. They want to see how these cells, what these cells are secreting, how these cells talk to each other, and what happens when these cells get inflamed. Inflammation is an incredibly important process that drives 50% of all deaths. And so this is another sort of disease agnostic approach. We want to understand inflammation. And they're going to get a ton of information out from these sensors that tell you What happens when something goes awry?

• 43:55Speaker 06

  Because right now, we can say, like, when you have an allergic reaction, your skin gets red and puffy. But what is the earliest signal of that? And these sensors can look at the behaviors of these cells over time. And then you can apply a large language model to look at the earliest statistically significant changes that can allow you to intervene as early as possible. So that's what Chicago's doing. They're starting in the skin cells. They're also looking at the neuromuscular junction, which is the connection between where a neuron attaches to a muscle and tells the muscle how to behave. Super important in things like ALS, but also in aging.

• 44:38Speaker 06

  The slowed transmission of information across that neuromuscular junction is what causes old people to fall. Their brain cannot trigger their muscles to react fast enough. And so we want to be able to embed these sensors to understand how these different interconnected systems within our bodies work together. In New York, they're doing a related, but equally exciting project where they're engineering individual cells to be able to go in and identify changes in a human body. So what they'll do is, they're calling it...

• 45:19Andrew D. Huberman?

  Wild. I mean, I love it. I mean, this is, I don't want to go on a tangent, but for those that want to look it up, adaptive optics, you know, there's a lot of distortion and interference when you try and look at something really small or really far away. And really smart physicists figured out, well, use the interference as part of the microscope. Make those actually lenses of the microscope. We should talk about imaging separately. So it's just, I mean, it's extremely clever along those lines. It's not intuitive, but then when you hear it, it's like, it makes so much sense.

• 45:48Speaker 06

  Yeah.

• 45:48Andrew D. Huberman?

  You know, it's not immediately intuitive. Make the cells that are already, can navigate to tissues or embed themselves in tissues, be the microscope within that tissue.

• 45:55Speaker 06

  Totally.

• 45:56Andrew D. Huberman?

  I love it.

• 45:56Speaker 06

  The way that I explain this to my friends and my family is, this is fantastic voyage, but real life. Um, like we are going into the human body and we're using the immune cells, which you know are privileged and already working to keep your body healthy. And being able to target them to examine certain things. So like you can engineer an immune cell to go in your body and look inside your coronary arteries and say, are these arteries um healthy or are there plaques? Because because plaques lead to blockage, which lead to heart attacks. Um, and the cell can then record that information and report it back out. That's the first half of what the New York Biohub is going to do.

• 46:38Andrew D. Huberman?

  Fantastic.

• 46:39Speaker 06

  The second half is can you then engineer the cells to go do something about it? Can I then tell a different cell, immune cell, that is able to transport in your body to go in and clean that up in a targeted way? And um, so I it's incredibly exciting. They're going to study things that are sort of immune privileged, that your immune system normally doesn't have access to. Um, things like ovarian and pancreatic cancer. Um, they'll also look at a number of neurodegenerative diseases since um, the immune system doesn't presently have a ton of access into the nervous system. Uh, but they it's it's both mind blowing and it feels like sci fi,

• 47:21Speaker 06

  but science is actually in a place where if you really pushed a group of incredibly qualified scientists, say, could you do this if given the chance? The answer is like, probably. Give us enough time, the bright team and resources, like it's doable.

• 47:37Speaker 05

  Yeah, I mean, it's a it's a 10 to 15 year project.

• 47:39Speaker 06

  Yeah.

• 47:40Speaker 05

  But it's it's awesome engineered cells, yeah.

• 47:43Andrew D. Huberman?

  I I love the optimism and and the moment you said make the cell the microscope. So it's we I was like, yes, yes, and yes, it it just makes so much sense. What motivated the decision to do the work of of C Z I um, in the context of existing universities as opposed to? You know, there's still some real estate up in Redwood City where there's a bunch of space to put biotech companies and just hiring people from all backgrounds and saying, "Hey, you know, have at it," and doing this stuff from scratch. I mean, it's a very interesting decision to do this in the context of an existing framework of like graduate students that need to do their thesis and get a first author paper. Because there's a whole set of structures within academia that I think both facilitate but also limit the progression

• 48:24Andrew D. Huberman?

  of science. You know, that independent investigator model that we talked about a little bit earlier, it's so core to the way science has been done. This is very different and frankly, sounds far more efficient if I'm to be completely honest. And, you know, we'll see if I renew my NIH funding after saying that. But I think we all want the same thing. We all want to, as scientists and as, you know, as humans, we want to understand the way we work and we want healthy people to persist to be healthy and we want sick people to get healthy. I mean, that's really ultimately the goal. It's not super complicated. It's just hard to do.

• 48:58Speaker 06

  So the teams at the Biohub are actually independent of the universities.

• 49:03Andrew D. Huberman?

  Got it.

• 49:03Speaker 06

  So each Biohub will probably have in total maybe 50 people working on sort of deep efforts. However, it's an acknowledgement that not all of the best scientists who can contribute to this area are actually going to, one, want to leave a university, or want to take on the full-time scope of this project. So it's the ability to partner with universities and to have the faculty at all the universities be able to contribute to the overall project is how the Biohub is structured.

• 49:38Andrew D. Huberman?

  Got it.

• 49:40Speaker 05

  But a lot of the way that we're approaching CZI is this long-term iterative project to figure out, try a bunch of different things, figure out which things produce the most interesting results, and then double down on those in the next five-year push, right? So we just went through this period where we kind of wrapped up the first five years of the science program. We tried a lot of different models, right? All kinds of different things. And it's not that the Biohub model, we don't think it's like... The best or only model, but we found that it was sort of a really interesting way to unlock a bunch of collaboration and bring some technical resources that allow for this longer term development. And it's not something that is widely being pursued across the rest of the

• 50:25Speaker 05

  field. So we figured, okay, this is like an interesting thing that we can that we can help push on. But I mean, yeah, we do believe in the collaboration. But I also think that we come at this with, you know, we don't think that the way that we're pursuing this is like, the only way to do this, or the way that everyone should do it. We're pretty aware of, you know, that, you know, what is the rest of the ecosystem and how we can play a unique role in it.

• 50:50Andrew D. Huberman?

  It feels very synergistic with the way science is already done, and also fills an incredibly important niche that frankly, wasn't filled before. Along the lines of implementation. So let's say, your large language models combined with imaging tools

• 51:07Andrew D. Huberman?

  reveal that a particular set of genes acting in a cluster, I don't know, set up an organ crash, let's say the pancreas crashes at a particular stage of pancreatic cancer. I mean, still one of the most deadliest of the cancers. And there are others that you certainly wouldn't want to get, but that's among the ones you wouldn't want to get the most. So you discover that. And then, and the idea is that, okay, then AI reveals some potential drug targets, then bear out in vitro in a dish and in a mouse model. How is the actual implementation of to drug discovery? Or even maybe this target is druggable, maybe it's not, maybe it requires some other approach, you know, laser, laser ablation approach

• 51:51Andrew D. Huberman?

  or something. We don't know. But ultimately, is CZI going to be involved in the implementation of new therapeutics? Is that the idea? Less so.

• 51:59Speaker 06

  Less so. That's, you know, this is where it's important to work in an ecosystem and to know your own limitations. Like, there are groups in startups and companies that take that and bring it to translation very effectively. I would say the place where we have a small window into that world is actually our work with rare disease groups. We have, through our Rare as One portfolio, funded patient advocates to create rare disease organizations where patients come together and actually pool their collective experience. They build

• 52:39Speaker 06

  bioregistries, registries of their natural history, and they both partner with researchers to do the research about their disease and with drug developers to incentivize drug developers to focus on what they may need for their disease. And, you know, one thing that's important to point out is that rare diseases aren't rare. There are over 7,000 rare diseases and collectively impact many, many individuals. And I think the thing that's, from a basic science perspective, the incredibly fascinating thing about rare diseases is that there are actually windows to how the body normally should work. And so there are often

• 53:24Speaker 06

  mutations that when genes that were, when they are mutated, cause very specific diseases, but that tell you how the normal biology works as well.

• 53:35Andrew D. Huberman?

  Got it. So, you discussed basically the goals, major goals and initiatives of the CZI for the next, say, five to 10 years. And then beyond that, the targets will be explored by biotech companies. They'll grab those targets and test them and implement them.

• 53:54Speaker 05

  There've also, I think, been a couple of teams from the initial BioHub that were interested in spinning out ideas, right into startups. So, that's just, even though it's not a thing that we're gonna pursue, because we're a philanthropy, we want to enable the work that gets done to be able to get turned into companies and things that other people go take and run towards building, you know, ultimately therapeutics. So, that's another zone. But that's just, that's not a thing that we're gonna do.

• 54:23Andrew D. Huberman?

  I gather you're both optimists. Yeah, is that part of what brought you together? Forgive me for switching to a personal question, but I love the optimism that seems to sit at the root of the CZI.

• 54:36Speaker 06

  I will say that we are incredibly hopeful people, but it manifests in different ways between the two of us.

• 54:44Speaker 05

  Yeah.

• 54:46Speaker 06

  What do you, how would you describe your optimism versus mine? It's not a loaded question.

• 54:50Speaker 05

  Um, I don't know.

• 55:02Speaker 05

  I mean, I think I'm more probably technologically optimistic about what can be built. And I think you, because of your focus as, you know, an actual doctor,

• 55:15Speaker 05

  kind of have more of a sense of how that's going to affect actual people in their lives. Whereas for me, it's like, I mean, a lot of my work is, you know, it's like we touch a lot of people around the world. And the scale is sort of immense. And I think for you, just like, it's like being able to improve the lives of individuals, whether it's, you know, students at any of the schools that you've started, or any of the stuff that we've supported through the education work, which isn't the goal here, or, you know, like, just being able to improve people's lives in that way, I think is the thing that I've seen you be super passionate about. I don't know, does that, do you agree with that characterization? I'm trying, I'm trying to.

• 55:57Speaker 06

  Yeah, I agree with that. I think that's very fair. And I'm sort of giggling to myself because in a day to day life as like life partners, our relative optimism comes through as Mark just like is overly optimistic about his time management and will get engrossed in interesting ideas.

• 56:17Speaker 05

  I'm late.

• 56:17Speaker 06

  And he's late.

• 56:19Andrew D. Huberman?

  Physicians are very punctual.

• 56:21Speaker 06

  And because he's late, I have to channel Mark is an optimist whenever I'm waiting for him.

• 56:26Speaker 05

  That's such a nice way. Okay, I'll start using that.

• 56:29Speaker 06

  That's what I think when I'm in the driveway with the kids waiting for you. I'm like, Mark is an optimist. Um, and so his optimism translates to some tardiness. Whereas I'm a sort of, I'm like, how does, what's, how is, how is this gonna happen? Like, I'm gonna open a spreadsheet, I'm gonna start putting together a plan and like, putting, pulling together all the pieces, calling people to sort of like, bring something to life.

• 56:55Speaker 05

  But it is, it's one of my favorite quotes that is, optimists tend to be successful and pessimists tend to be right. And, yeah, I mean, I think it's, it's true in a lot of different aspects of life.

• 57:08Andrew D. Huberman?

  We know who said that? Did you say that?

• 57:10Speaker 05

  No, no, no, I did not, I did not.

• 57:12Speaker 06

  Absolutely not.

• 57:14Speaker 05

  I like it. I did not invent it.

• 57:16Andrew D. Huberman?

  We'll give it to you. We'll put it out there.

• 57:18Speaker 05

  No, no, no, no, no. But, but I, I do think that there's really something to it, right? And there's like, if you're discussing any idea, there's all these reasons why it might not work. And so I, I think that, and those reasons are, you know, probably true. The people who are stating them are, you know, probably have some validity to it. But the question is that, is that the most productive way to view the world? And, you know, I think across the board, and I think the people who tend to be the most productive and get the most done, you kind of need to be optimistic because if you don't believe that something can get done, then why would you go work on it?

• 57:53Andrew D. Huberman?

  The reason I ask the question is that, you know, that these days we hear a lot about, you know, the future is looking so dark in these various ways. And you have children, so you have families and you are a family, excuse me, and, and you also have families independently that are now merged. But I love the optimism behind the CCI because, you know, you know, behind all this, there's sort of a set of big statements on the wall. One, the future can be better than the present in terms of treating disease. Maybe even, you said eliminating diseases, all diseases. I love that optimism. And that there's a tractable path to do it.

• 58:34Andrew D. Huberman?

  Like, we're gonna put literally, you know, money and time and energy and people and technology and AI behind that. And so I have to ask, was Having children, a significant modifier in terms of your view of the future like wow, like you hear all this doom and gloom, like what's the future going to be like for them? Did you sit back and think, you know, what would it look like if there was a future with no diseases? Is that the future we want our children in? I mean, I'm voting a big yes. So we're not gonna, we're not gonna debate that at all. But was having children a sort of an inspiration for the CZI in some way? Yeah.

• 59:11Speaker 06

  So I think my answer to that, I would dial backwards for me. And I'll just tell a very brief story about my family. I'm the daughter of Chinese Vietnamese refugees. My parents and grandparents were boat people. If you remember, people left Vietnam during the war in these small boats into the South China Sea. And the, there were stories about how these boats would sink with whole families on them. And so my grandparents, both sets of grandparents who knew each other, decided that there was a better future out there and they were willing to take risks for it. But they were afraid of losing all of their kids.

• 59:54Speaker 06

  My dad is one of six, my mom is one of 10. And so they decided that there was something out there in this bleak time and they paired up their kids, one from each family, and sent them out on these little boats before the internet, before cell phones, and said, we'll see you on the other side.

• 1:00:17Andrew D. Huberman?

  Wow.

• 1:00:18Speaker 06

  And the kids were between the ages of like, you know, 10 to 25. So young kids. My mom was a teenager, early teen when this happened. And everyone made it. And I get to sit here and talk to you. So how could I not believe that like, better is possible? And like, I hope that that's in my like epigenetics somewhere and then I carry that on.

• 1:00:44Andrew D. Huberman?

  That is a spectacular story.

• 1:00:45Speaker 06

  Isn't that wild?

• 1:00:46Andrew D. Huberman?

  It is spectacular.

• 1:00:47Speaker 06

  How can I be a pessimist with that?

• 1:00:48Andrew D. Huberman?

  I love it. Well, and I so appreciate that you became a physician because you're now bringing that. Optimism and that epigenetic understanding and cognitive understanding and emotional understanding to the field of medicine. And so I'm grateful to the people that made that decision.

• 1:01:05Speaker 06

  Yeah. And then, you know, when I think you don't, I've always known that story, but you don't understand how wild that feels until you have your own child. And you're like, well, I can't even, I refuse to let her use, you know, glass bottles only or something like that. And you're like, oh, my God, like the risk and sort of willingness of my grandparents to believe in something bigger and better is just astounding. And it also, and our own children sort of give it a sense of urgency.

• 1:01:35Andrew D. Huberman?

  And spectacular story and you're sending knowledge out into the fields of science and bringing knowledge into the fields of science. And I love this. We'll see you on the other side.

• 1:01:45Speaker 06

  Yeah.

• 1:01:45Andrew D. Huberman?

  I'm confident that it will all come back.

• 1:01:49Andrew D. Huberman?

  Well, thank you so much for that. I mark out, you have the opportunity to talk about, did having kids change your worldview?

• 1:01:57Speaker 05

  It's really tough to beat that story.

• 1:01:59Andrew D. Huberman?

  It is tough to beat that story. And they are also your children. So in this case, you get, you get two for the price of one, so to speak. So.

• 1:02:09Speaker 05

  Having children definitely changes your time horizon. Something that that's one thing is you just, like, there are all these things that I think we had talked about for as long as we've known each other, that you eventually want to go do. But then it's like, oh, we're having kids. We need to like, get on this, right? So I think there's.

• 1:02:24Speaker 06

  That was actually one of the checklists, the baby checklist before the first.

• 1:02:28Speaker 05

  It was like, the baby's coming. We have to like, start CZI.

• 1:02:31Speaker 06

  Truly.

• 1:02:32Speaker 05

  And like, sitting in the hospital delivery room, finishing, editing the letter that we were going to publish to announce the work.

• 1:02:41Speaker 06

  Some people think that is an exaggeration. It was not. We really were editing the final draft.

• 1:02:46Andrew D. Huberman?

  Birth CZI before you birth the human child. Well, it's, it's an incredible initiative. I've, I've been following it since its inception and, and it's already been tremendously successful and everyone in the field of science, and I have a lot of communication with those folks, feels the same way and, and the future is even brighter for it. It's clear. And thank you for expanding to the Midwest and New York. And we're all very excited to see where all of this goes. I share in your optimism. And thank you for your time today.

• 1:03:18Speaker 06

  Thank you.

• 1:03:19Speaker 05

  Thank you. A lot more to do.

• 1:03:21Andrew D. Huberman?

  And now for my discussion with Mark Zuckerberg. Slight shift of topic here. You're extremely well-known for your role in technology development. But by virtue of your personal interests and also where meta-technology interfaces with mental health and physical health, you're starting to become synonymous with health, whether you realize it or not. Part of that is because there's posts, footage of you rolling jiu-jitsu, you won a jiu-jitsu competition recently, you're doing other forms of martial arts, water sports, including surfing, and on and on.

• 1:04:00Andrew D. Huberman?

  So you're doing it yourself, but maybe we could just start off with technology and get this issue out of the way first, which is that I think many people assume that technology, especially technology that involves a screen, excuse me, of any kind, is going to be detrimental to our health. But that doesn't necessarily have to be the case. So could you explain how you see technology meshing with, inhibiting, or maybe even promoting physical and mental health?

• 1:04:35Speaker 05

  Sure. I mean, I think this is a really important topic. It's, you know, the research that we've done suggests that it's not like all good or all bad. I think how you're using the technology has a big impact on whether it is basically a positive experience for you. And even within technology, even within social media, there's not kind of one type of thing that people do. I think at its best, you're forming meaningful connections with other people. And there's a lot of research that basically suggests that, you know, it's the relationships that we have and friendships that kind of bring the most happiness in our lives and

• 1:05:19Speaker 05

  at some level end up even correlating with living a longer and healthier life because that kind of grounding that you have in community ends up being important for that. So I think that that aspect of social media... Which is, you know, the ability to connect with people, to understand what's going on in people's lives, have empathy for them, communicate what's going on with your life, express that. That's generally positive. There are ways that it can be negative in terms of bad interactions, things like bullying, which we can, we can talk about because there's a lot that we've done to basically make sure that people can be safe from that and give people tools and give kids the ability to have the right parental controls, that their parents can oversee that. But that's sort of the interacting with people side.

• 1:06:02Speaker 05

  There's another side of all this, which I think of as just like passive consumption, which at its best, it's entertainment, right? And entertainment is an important human thing too. But I don't think that that has quite the same association with the long-term well-being and health benefits as being able to help people connect with other people does. And I think at its worst, some of the stuff that we see online, you know, I think these days a lot of the news is just so relentlessly negative that it's just hard to, you know,

• 1:06:43Speaker 05

  come away from an experience where you're, you know, looking at the news for half an hour and like feel better about the world. So I think that there's a mix on this. I think the more that social media is about connecting with people, and the more that when you're kind of consuming and using the media part of social media to learn about things that can enrich you and can provide inspiration or education as opposed to things that just leave you with a more toxic feeling, that that's sort of the, the balance that we try to, to get right across our products. And I think we're pretty aligned with the community because at the end of the day, you know, I mean, people don't want to use

• 1:07:28Speaker 05

  a product and come away feeling bad. You know, there's a lot that people talk about.

• 1:07:34Speaker 05

  evaluate a lot of these products in terms of information and utility. But I think it's as important when you're designing a product to think about what kind of feeling you're creating with the people who use it, right? Whether that's kind of an aesthetic sense when you're designing hardware or just kind of like what, like what do you, what do you make people feel? And generally, people don't want to feel bad, right? So I, I think when, you know, that doesn't mean that we want to, you know, shelter people from bad things that are happening in the world. But I, I don't really think that, you know, it's not what people want, um, you know, for us to just be kind of just showing like all this super negative stuff all day long. Um, so we, so we work hard on all these different problems, you know, making sure that we're

• 1:08:16Speaker 05

  helping connect people as best as possible, helping make sure that we give people good tools, um, to block people who might be bullying them or harass them, or especially for younger folks, you know, anyone under the age of 16 defaults into an experience where their experience is private. We have all these parental tools, um, so that way, you know, parents can, can kind of understand what, what their children is up to and are up to in a good balance. Um, you know, and then on the other side, we try to give people tools to understand how they're spending their time. Um, and we try to give people tools so that, you know, if you're, if you're a teen and, and you're kind of stuck in some, you know, loop of, of just looking at one type of content will nudge you and say, hey, you've been looking at content of this type for a while. Like, how about something else? And here's, here's a bunch of other examples.

• 1:09:00Speaker 05

  So I think that there are things that you can do to kind of push this in a positive direction, but I think it just starts with having a more nuanced view of like, this isn't all good and all, or all bad. And the more that you can make it kind of a positive thing, the, the better this will be for all the people who use our products.

• 1:09:15Andrew D. Huberman?

  That makes really good sense. In terms of the negative experience, I agree. I don't think anyone wants a negative experience in the moment. I think where some people get concerned perhaps, and I think about my own interactions with, say Instagram, which I use all the time, um, for getting information out, but also consuming information. And I happen to love it. It's where I essentially launched the non podcast segment of my podcast and continue to. I can think of experiences that are a little bit like highly processed food, where it tastes good at the time, it's highly engrossing, but it's not necessarily nutritious and you don't feel very good afterwards. So for me, that would be my, the little collage of default options to click on in Instagram.

• 1:10:00Andrew D. Huberman?

  Occasionally, I notice, and this just reflects my failure, not Instagram's, right? That there are a lot of like, street fight things, like of people beating people up on the street. And I have to say, these have a very strong gravitational pull. I'm not somebody that enjoys seeing violence per se, but you know, I find myself, I'll click on one of these, like, what happened? And I'll see someone like, you know, get hit, and there's like, a little melee on the street or something, and those seem to be offered to me a lot lately. And again, this is my fault. It reflects my prior searching experience. But I noticed that it has a bit of a gravitational pull where, you know, I didn't learn anything. It's not teaching me any kind of useful, street, self-defense skills of any kind.

• 1:10:43Andrew D. Huberman?

  And at the same time, I also really enjoy some of the cute animal stuff. And so I get a lot of those also. So there's this polarized, you know, collage that's offered to me that reflects my prior search behavior. You could argue that the cute animal stuff is just entertainment, but actually, it fills me with a feeling, in some cases, that truly delights me. I delight in animals. And we're not just talking about kittens, I mean, animals I've never seen before, interactions between animals I've never seen before, that truly delight me, they energize me in a positive way, that when I leave Instagram, I do think I'm better off. So I'm grateful for the algorithm in that sense. But I guess the direct question is, is the algorithm just reflective of what one has

• 1:11:26Andrew D. Huberman?

  been looking at a lot, prior to that moment where they log on? Or is it also trying to do exactly what you described, which is trying to give people a good feeling experience that leads to more good feelings?

• 1:11:39Speaker 05

  Yeah, I mean, I think we try to do this in a long term way. Right. I think one simple example of this is we had this issue a number of years back about clickbait news. Right. So articles that would have, um, you know, basically a headline that grabbed your attention that made you feel like, oh, I need to click on this. Then you click on it and then the article is actually, you know, about something that's somewhat tangential to it. But people clicked on it. So, you know, the naive version of this stuff, you know, the like 10 year old version. It was like, oh, people seem to be clicking on this. Maybe that's good. But it's actually a pretty straightforward exercise to instrument the system to realize that, hey, people click on this.

• 1:12:18Speaker 05

  And then, you know, they don't really spend a lot of time reading the, the news that after clicking on it. And, um, after they do this a few times, they, you know, it doesn't really correlate with them, you know, saying that they're having a good experience. Some of what you, some of how we, we measure this is just by looking at how people use the services. But I think it's also important to balance that by having like real people come in and, you know, tell us, okay. We, we show them, here are the stories that we could have showed you. Which of these are most meaningful to you or would, would make it so that you have the best experience? And just kind of like mapping the algorithm and what we do to that ground truth of what people say that they want.

• 1:13:00Speaker 05

  So I, I think that through a set of things like that, we really have made large steps to minimize things like clickbait over time. It's not like gone from the internet, but you know, I think we've done a good job of minimizing it on our services. Within that though, I do think that we need to be pretty careful about not being paternalistic about what makes different people feel good. Right. So, I mean, I don't know that everyone feels good about, about cute animals. And I can't imagine that people would feel really bad about it, but maybe they don't have as profound of a positive reaction to it as, as you just expressed.

• 1:13:35Speaker 05

  And I don't know, maybe people who are more into fighting would look at the, you know, the street fighting videos, assuming that they're within our community standards. I think that there's a level of violence that we just don't want to be showing at all, but that's a, a separate question. But if they are, I mean, then, you know, it's like, I mean, I'm pretty into MMA. I don't, I don't get a lot of street fighting videos, but if I did, maybe I'd feel like I was learning something from that. I think at various times in the company's history, we've been a little bit too paternalistic about saying, this is good content, this is bad, you should like this, this is unhealthy for you. And I think that we want to look at the long-term effects. You don't want to get stuck in a short-term loop of like, okay, just because you did this today doesn't mean it's like

• 1:14:19Speaker 05

  what you aspire for yourself over time. But I think as long as you look at the long-term of what people both say they want and what they do, giving people a fair amount of latitude to like the things that they like, I just think feels like the right set of values to bring to this. Now, of course, that doesn't go for everything. There are things that are kind of truly off limits and, and you know, things that like bullying, for example, or you know, things that are really like inciting violence, things like that. I mean, we have the whole community standards around this. But I think, except for those things, which I would hope that most people can agree, okay, bullying is bad, right? I hope that, you know, 100% of people agree with that. And you know, not 100, maybe 99%.

• 1:15:04Speaker 05

  Except for the things that kind of get that sort of very, that feel pretty extreme and bad like that. I think you want to give people space to like what they want to like.

• 1:15:15Andrew D. Huberman?

  Yesterday, I had the very good experience of learning from the meta team about safety protections that are in place for kids who are using meta platforms. And frankly, I was like really positively surprised at the huge number of filter-based tools and, and, and just ability to customize the experience so that it can stand the best chance of enriching, not just remaining neutral, but enriching their mental health status.

• 1:15:45Speaker 05

  Yeah.

• 1:15:46Andrew D. Huberman?

  One thing that came about in that conversation, however, was I realized there are all these tools, but do people really know that these tools exist? And I think about my own experience with Instagram. I love watching Adam Mosseri's Friday Q and As because he explains a lot of the tools that I didn't know existed. And if people haven't seen that, I highly recommend that they watch that. I think every takes questions on Thursdays and answers them most every Fridays. So if I'm not aware of the tools without watching that, that exists for adults.

• 1:16:22Andrew D. Huberman?

  How does Meta look at the challenge of making sure that people know that there are all these tools? I mean, dozens and dozens of very useful tools, but I think most of us just know the hashtag, the tag, the click, Stories versus Feed. We now know that I also post to Threads. I mean, so we know the major channels and tools, but this is like owning a vehicle that has incredible features that one doesn't realize can take you off-road, can allow your vehicle to fly. I mean, there's a lot there. So what do you think could be done to get that information out? Maybe this conversation could cue people to their existence.

• 1:16:55Speaker 05

  I mean, that's part of the reason why I wanted to talk to you about this is, I mean, I think most of the narrative around social media is not, okay, all of the different tools that people have to control their experience. It's the kind of narrative of, is this just negative for teens or something? And I think, again, a lot of this comes down to, you know, how is the experience being tuned? And is it actually, you know, like, are people using it to connect in positive ways? And if so, I think it's really positive. So, yeah, I mean, I think part of this is, we probably just need to get out and talk to people more about it. And then there's an in-product aspect, which is, you know, if you're a teen and you sign up,

• 1:17:38Speaker 05

  we take you through a pretty extensive experience that tries to outline some of this. But that has limits too, right? Because when you sign up for a new thing, if you're bombarded with like, here's a list of features, you're like, okay, I just signed up for this. I don't really understand much about what the service is. Like, let me go find some people to follow who are my friends on here before I like, learn about controls to prevent people from harassing me or something. That's why I think it's really important to also show a bunch of these tools in context. So, you know, if you're looking at comments and, you know, if you go to delete a comment or you go to edit something, you know, try to give people prompts in line.

• 1:18:22Speaker 05

  It's like, hey, did you know that you can manage things in these ways around that? Or when you're in the inbox and you're filtering something, right? It's remind people in line. So I note, just because of the number of people who use the products and the level of nuance around each of the controls, I think the vast majority of that education, I think, needs to happen in the product. But I do think that through conversations like this and others that we need to be doing. And we can create a broader awareness that those things exist so that way at least people are primed. So that way, when those things pop up in the product, people are like, oh, yeah, like I knew that there was this control and like, here's, here's like how I would use that.

• 1:19:03Andrew D. Huberman?

  Like I find the restrict function to be very useful, more than the block function. In most cases, I do sometimes have to block it. But the restrict function is really useful that you could filter specific comments. You know, someone might have a, you might recognize that someone has a tendency to be a little aggressive. And I should point out that I actually don't really mind what people say to me, but I try and maintain what I call classroom rules in my comment section where I don't like people attacking other people. Because I would never tolerate that in the university classroom. I'm not going to tolerate that in the comment section, for instance.

• 1:19:31Speaker 05

  Yeah. And I think that the example that you just, you just used about restrict versus block gets to something about product design that's important too. Which is that block is sort of this very powerful tool that if someone is giving you a hard time and you just want them to disappear from the experience, you can do it. But the design trade off with that is that in order to make it so that the person is just gone from the experience.

• 1:19:59Speaker 05

  And that you don't show up to them, they don't show up to you. Inherent to that is that they will have a sense that you blocked them. And that's why I think some stuff like restrict or just filtering, like I just don't want to see as much stuff about this topic. You know, people like using different tools for very subtle reasons, right? I mean, maybe, maybe you want the content to not show up. But you don't want the person who's posting the content to know that you don't want it to show up. Maybe you don't want to get the messages in your main inbox, but you don't want to tell the person that you like, that you actually, you know, that you're not friends or something like that. And you actually need to give people different tools that have different levels of, of kind of power and nuance around.

• 1:20:42Speaker 05

  How the social dynamics around using them play out in order to really allow people to tailor the experience in the ways that they want.

• 1:20:49Andrew D. Huberman?

  In terms of trying to limit total amount of time on social media, I couldn't find really good data on this. You know, how much time is too much? I mean, I think it's going to depend on what one is looking at, the age of the user, etc.

• 1:21:05Speaker 05

  Yeah, I agree.

• 1:21:06Andrew D. Huberman?

  But I know that you have tools that cue the user to how long they've been on a given platform. Are there tools to self-regulate? Like, I'm thinking about like the Greek myth of the sirens and, you know, people, you know, tying themselves to the mast and covering their eyes so that they're not drawn in by the sirens. Is there a function aside from deleting the app temporarily and then reinstalling it every, every time you want to use it again? Is there a true lockout, self-lockout function where one can lock themselves out of access to the app?

• 1:21:35Speaker 05

  Well, I think we give people tools that let them manage this and, and, and there's the tools that you get to use and then there's the tools that the parents get to use to basically see how the usage works. But yeah, I think that there's, there's different kind of, you know, I think for now we've mostly focused on, you know, helping people understand this and then, you know, give people reminders and things like that. It's tough, though, to answer the question that you were talking about before this of is there an amount of time which is too much? Because it does really get to what you're doing. But if you fast forward beyond just the apps that we have today to an experience that is like a social experience in the future of the augmented reality glasses or something

• 1:22:18Speaker 05

  that, that we're building, a lot of this is going to be, you know, you're interacting with people in the way that you would physically as if you were kind of like hanging out with friends or working with people. But now they can show up as holograms and you can feel like you're present right there with them, no matter where they actually are. And the question is, Is there too much time to spend interacting with people like that? Well, at the limit, if we can get that experience to be kind of as rich and giving you as good of a sense of presence as you would have if you were physically there with someone, then I don't see why you would want to restrict the amount that people use that

• 1:23:00Speaker 05

  technology to any less than what would be the amount of time that you'd be comfortable interacting with people physically, which obviously is not going to be 24 hours a day. You have to do other stuff. You have work, you need to sleep. But I think it really gets to kind of how you're using these things. Whereas if what you're primarily using the services for is to, you're getting stuck in loops, reading news or something that is really kind of getting you into a negative mental state, then, I don't know, I mean, I think that there's probably a relatively short period of time that maybe that's kind of a good thing that you want to be doing. But again, even then, it's not zero, right? Because it's, you know, just because news might make you unhappy doesn't mean that the answer is to be unaware of negative things that are happening in the world.

• 1:23:45Speaker 05

  I just think that there's like, different people have different tolerances for what they can take on that. And I think we, you know, it's generally having some awareness is probably good as long as it's not more than you're kind of constitutionally able to take. So, I don't know. Try to not be too paternalistic about this is our approach, but we want to empower people by giving them the tools, both people and if you're a teen, your parents, to have tools to understand what you're experiencing and what the, and how you're using these things and then, and then go from there.

• 1:24:17Andrew D. Huberman?

  Yeah, I think it requires of all of us some degree of self-regulation. I like this idea of not being too paternalistic. I mean, that's, it seems like the right way to go. I find myself occasionally having to make sure that I'm not just passively scrolling, that I'm learning. I like forging. For organizing and dispersing information. That's been my, my, my life's career. So I have, I've learned so much from social media. I find great papers, great ideas. I think comments are a great source of feedback and I'm not just saying that because you're sitting here. I mean, Instagram in particular, but other meta platforms have been tremendously helpful for me to get science and health information out. One of the things that I'm really excited about,

• 1:24:56Andrew D. Huberman?

  which I only had the chance to try for the first time today, is your new VR platforms, the newest Oculus. And when then we can talk about the glasses, the Ray-Bans. Sure. Those are still, that, those two experiences are still kind of blowing my mind, especially the, the, the, the Ray-Ban glasses. And I have so many questions about this, so I'll resist, but. We can get into that. Okay. Well, yeah, I have some experience with VR. My lab has used VR. Jeremy Balenson's lab at, at Stanford is one of the pioneering labs of VR and, and mixed reality. I guess some, they used to call it augmented reality, but now mixed reality. I think what's so striking about the VR that you guys had me try today is how well it interfaces with the,

• 1:25:39Andrew D. Huberman?

  with the real room. Let's call it the, the physical room. I could still see people. I could see where the furniture was. So I did, wasn't going to bump into anything. I could see people's smiles. I could see my, my, um, my water on the table while I was doing this, what felt like a real martial arts experience, except I wasn't getting hit. Well, I was getting hit virtually, but it's extremely engaging. And yet it, on the good side of things, it really bypasses a lot of the early concerns that Balenson lab, again, Jeremy's lab was early to say that, oh, you know, there's a limit to how much VR one can, or should use each day, um, even for the adult brain, because it can really disrupt your vestibular system,

• 1:26:21Andrew D. Huberman?

  your sense of balance. All of that seems to have been dealt with in this new, this new iteration of VR. Like, I didn't come out of it feeling dizzy at all. I didn't feel like I was re-entering the room in a way that was really jarring. Going into it is obviously, whoa, this is a different world, but you can look, look to your left and say, oh, someone just came in the door. Hey, how's it going? Hold on, I'm playing this game. Just as it was when I was a kid playing a Nintendo and someone would walk in. It's fully engrossing, but you'd be like, hold on. And you see they're there. So first of all, um, Bravo. Incredible. And then the next question is, you know, what is this? What do we even call this experience? Because it is truly mixed. It's a truly mixed reality experience.

• 1:27:00Speaker 05

  Yeah, I mean, mixed realities is sort of the umbrella term that refers to the combined experience of virtual and augmented reality. So augmented reality is, you know, what you're eventually going to get with, you know, some future version of the smart glasses where you're primarily seeing the world, right? But, um, but you can put holograms in it, right? So like that will have a, you know, future where you're going to walk into a room and there are going to be like as many holograms as, as physical objects, right? If you just think about like all the paper, the kind of art, physical games, media, your workstation.

• 1:27:34Andrew D. Huberman?

  If we refer to, let's say, an MMA fight, we could just draw it up on the table right here and just see it repeat as opposed to us turning and looking at a screen.

• 1:27:40Speaker 05

  Yeah, I mean, pretty much any screen that exists could be a hologram in the future with smart glasses, right? There's nothing that actually physically needs to be there for that when you have glasses that can put, um, a hologram there. And, and it's an interesting thought experiment to just go around and think about, okay, what of the things that are physical in the world need to actually be physical? And your chair does, right? Cause you're sitting on it. A hologram isn't going to support you, but I like that art on the wall. I mean, that doesn't need to physically be there. I mean, um, so I, I think that that's, that's sort of the augmented reality experience that we're moving towards. And then we've had these headsets that historically we think about as VR. And that has been something that kind of, it's like a fully immersive experience.

• 1:28:25Speaker 05

  But now we're kind of getting something that's a hybrid in between the two and capable of both, which is a headset that can do both virtual reality and some of these augmented reality experiences. And I think that that's really powerful, um, both because you're going to get new applications that, that kind of allow people to collaborate together. And, um, you know, maybe the two of us are here physically, but you know, someone joins us and it's their avatar there. Or maybe, you know, it's some version in the future, like we're having a, you know, you're having a team meeting and you have some people there physically and you have some people dialing in and they're basically like a hologram there virtually, but then you also have some AIs that personas that are on your team that are helping you do different things. They can be embodied as avatars and around the table meeting with you.

• 1:29:07Andrew D. Huberman?

  Are people going to be doing first dates that are physically separated? I could imagine that some people would, is it even worth leaving the house type date? And then they find out and then they meet for the first time.

• 1:29:17Speaker 05

  Um, I mean, maybe I think, I think, you know, I dating has physical aspects to it too.

• 1:29:24Andrew D. Huberman?

  And some people might not be, they want to know whether or not it's worth the effort to head out to what we're not.

• 1:29:30Speaker 05

  You know, it is possible.

• 1:29:31Andrew D. Huberman?

  The divide, right?

• 1:29:32Speaker 05

  It is possible. I mean, I know like a, some of my friends who are dating basically. Yeah. Say that in order to make sure that they have like a safe experience. And when they're, if they're going on a first date, they'll schedule something that's like shorter and maybe in the middle of the day. Like, so maybe it's coffee. So that way, if they don't like the person, they can just kind of get out before like going and scheduling a dinner or like a real full date. So I don't know, maybe in the future, people will, will kind of have that experience where you can feel like you're kind of sitting there and it's. And it's even easier and lighter weight and safer. And if you're not having a good experience, you can just like teleport out of there and beyond. But yeah, I think that this will be an interesting question in the future is.

• 1:30:15Speaker 05

  There are clearly a lot of things that are only possible physically that, or are so much better physically. And then there were all these things that were building up that can be digital experiences. But it's this weird artifact of kind of how the stuff has been developed that. The digital world and the physical world exist in these like completely different planes. Where you want to interact with the digital world. Well, we do it all the time, but we pull out a small screen or we have a big screen. And it's just basically we're interacting with the digital world through these screens. But I think if we fast forward, you know, a decade or more, it's. I think one of the really interesting questions about what. Like what is the world that we're going to live in? I think it's going to increasingly be this mesh of the physical and digital worlds

• 1:30:58Speaker 05

  that will allow us to feel, A, that the world that we're in is just a lot richer, because there can be all these things that people create that are just so much easier to do digitally than physically.

• 1:31:10Speaker 05

  But, and B, you're going to have a real kind of physical sense of presence with these things and not feel like interacting in the digital world is taking you away from the physical world, which today is just so much viscerally richer and more powerful. I think the digital world will sort of be embedded in that and will feel kind of just as vivid in a lot of ways. So that's why I always think, when you were saying before, you felt like you could look around and see the real room. I actually think that there's an interesting kind of philosophical distinction between the real room and the physical room, which historically, I think people would have said those are the same thing. But I actually think in the future, the real room is going to be the combination of the

• 1:31:52Speaker 05

  physical world with all the digital artifacts and objects that are in there that you can interact with them and feel present, whereas the physical world is just the part that's physically there. And I think it's possible to build a real world that's the sum of these two that will actually be a more profound experience than what we have today.

• 1:32:08Andrew D. Huberman?

  I was struck by the smoothness of the interface between the VR and the physical room. Your team had me try a, I guess it was an exercise class in the form of a, it was like, essentially like hitting mitts boxing, so hitting targets boxing.

• 1:32:22Speaker 05

  Supernatural?

• 1:32:23Andrew D. Huberman?

  Yeah, and it comes at a fairly fast pace. It then picks up. It's got some tutorials. It's very easy to use and certainly got my heart rate up. I'm in at least decent shape. And I have to be honest, I never once desired to do any of these on-screen fitness things. I mean, I can't think of anything more aversive than like a clap, like, I don't want to insult any particular products, but like riding a stationary bike while looking at a screen and pretending I'm on a road outside. I can't think of anything worse for me. Maybe.

• 1:32:53Speaker 05

  I do like the leaderboard. But maybe I'm just a very competitive person. It's like, if you're going to be running on a treadmill, at least give me a leaderboard so I can beat the people who are ahead of me.

• 1:33:01Andrew D. Huberman?

  I like moving outside and certainly an exercise class or aerobics classes, they used to call them, but. What the experience I tried today was extremely engaging. Um, and I've done enough boxing to at least know how to do a little bit of it. And I really enjoyed it, gets your heart rate up. And you, I completely forgot that I was doing an on-screen experience because in part because I believe I was still in that physical room. And I think there's something about the mesh of the physical room and the virtual experience that makes it neither of one world or the other. I mean, I really felt at the interface of those and, and certainly got presence, this feeling of forgetting that I was in a virtual experience. And got my heart rate up pretty quickly.

• 1:33:45Andrew D. Huberman?

  We had to stop because we were going to start recording, but I would do that for a good 45 minutes in the morning.

• 1:33:49Speaker 05

  Yeah.

• 1:33:50Andrew D. Huberman?

  And, and there's no amount of money you could pay me truly to look at a screen while pedaling on a bike or running on a treadmill. So, um, again, bravo. I think it's going to be very useful. It's going to get people moving their bodies more, which certainly social media up until now and a lot of technologies have been accused of limiting the amount of physical activity that, that both children and adults are engaged in. So, and we know we need physical activity. You're a big proponent of and practitioner of physical activity. So is this a major goal of Meta? Get people moving their bodies more and getting their heart rates up and, and so on?

• 1:34:27Speaker 05

  I think we want to enable it and I, I think it's good, but I, I think it comes more from like a philosophical view of the world than it is necessarily. I mean, I, I don't go into building products to try to shape people's behavior, right? I, I believe in empowering people to, you know, do what they want and be the best version of themselves that they can be.

• 1:34:51Andrew D. Huberman?

  So no agenda.

• 1:34:53Speaker 05

  That said, I, I do believe that, you know, there's the, the previous generation of computers were devices for your mind. And I think that we are not brains in tanks. You know, it's like, I think that there's sort of a philosophical view of people of like, okay, you, you are primarily, you know, what you think about or your values or something. It's like, no, you are that and you are a physical manifestation and people are, were very physical. And I think building a computer.

• 1:35:24Speaker 05

  For your whole body and not just for your mind is very fitting with this worldview that like the actual essence of you, if you want to be present with another person, if you want to like be fully engaged and experience is not just, okay, it's not just a video conference call that looks at your face and where you can like share ideas. It's, it's something that, that you can engage your whole body. So yeah, I mean, I think being physical is very important to me. I mean, it's, um, you know, it's, it just, that's a lot of, you know, the most fun stuff that I get to do. Um, it's a really important part of how I personally balance my energy levels and just get a diversity of experiences

• 1:36:07Speaker 05

  because I could spend all my time running the company. Um, but I think it's good for people to do some different things and, you know, compete in different areas or learn different things. And all of that is good. If, if people want to, you know, do really intense workouts with, um, with the work that we're doing with Quest or with, um, you know, eventual AR glasses, great. But even if you don't want to do like a really intense workout, I think just having a computing environment and platform, which is inherently physical, captures more of the essence of what we are as people than any of the previous computing platforms that we've had to date.

• 1:36:47Andrew D. Huberman?

  I was even thinking just of the, um, simple task of getting a better range of motion, AKA flexibility. I could imagine inside of the VR experience, you know, leaning into a stretch, you know, a standard kind of like, like a lunge type stretch, but actually seeing a meter of like, are you get, are you approaching new levels of flexibility in that moment where it's actually measuring some, some kinesthetic elements on the body and the joints. And I mean, I was just trying, whereas normally you might have to do that in front of a camera, which then would give you the data on a screen that you'd look at afterwards or hire an expensive coach, but so, or looking at form and resistance training. So you're actually lifting physical weights, but it's telling you whether or not you're breaking form. I mean, there's just so much that could be done inside of

• 1:37:28Andrew D. Huberman?

  there. And then my mind just starts to spiral into like, wow, this is very likely to transform what we think of as quote unquote, exercise.

• 1:37:36Speaker 05

  Yeah, I think so. I think there's still a bunch of questions that need to get answered. You know, I don't think most people are gonna necessarily want to install, you know, a lot of sensors or cameras to track their whole body. So we're just over time getting better from the sensors that are on the headsets of being able to do very good hand tracking, right? So we have this research demo where you now, just with the hand tracking from the headset, you can type. It just projects a little keyboard onto your table and you can type and people like type like 100 words a minute with that.

• 1:38:07Andrew D. Huberman?

  With a virtual keyboard.

• 1:38:08Speaker 05

  Yeah, we're starting to be able to, using some modern AI techniques, be able to like simulate and understand where your torso's position is. Even though you can't always see it, you can see it a bunch of the time. And if you fuse together what you do see with like the accelerometer and understanding how the thing is moving, you can kind of understand what the body position is gonna be. But some things are still gonna be hard, right? So you mentioned boxing. That one works pretty well because, you know, we understand your head position. We understand your hands. And now we're kind of increasingly understanding your body position.

• 1:38:50Speaker 05

  But let's say you want to expand that to Muay Thai or kickboxing. Okay, so legs, that's a different part of tracking. That's harder because that's out of the field of view more of the time. But there's also the element of resistance, right? So you can throw a punch and retract it and shadow box and, you know, do that without upsetting your kind of physical balance that much. But if you want to throw a roundhouse kick and there's no one there, then, I mean, you know, the standard way that you do it when you're shadow boxing is you basically do a little 360. But like, I don't know, is that, is that gonna feel great? I mean, I think there's a question about what that experience should be. And then if you want to go even further, if you want to get like grappling to work,

• 1:39:33Speaker 05

  I'm not even sure how you would do that without having resistance of understanding what the forces applied to you would be. And just then you get into, okay, maybe you're going to have some kind of body suit that can apply, you know, haptics, but I'm not even sure that that even a pretty advanced haptic system is going to be able to be quite good enough to do to simulate like the actual forces that would be applied to you in a grappling scenario. So this is part of what's fun about technology, though, is you get, we keep on getting new capabilities, and then you need to figure out what things you can do with them. So I think it's really neat that we can kind of do boxing and we can do the supernatural thing. And there's a bunch of awesome cardio and dancing and things like that. And then there's also still so much more to do that that I'm excited to to kind of get to over time. But but it's a it's a long journey.

• 1:40:17Andrew D. Huberman?

  And what about things like painting and art and music?

• 1:40:21Speaker 05

  Yeah.

• 1:40:22Andrew D. Huberman?

  You know, I imagine, you know, of course, you like different mediums, like I like to draw with pen and pencil, but I could imagine trying to learn how to paint in virtually. And of course, you could print out a physical version of that at the end. This doesn't have to depart from the physical world. It could end in the physical world.

• 1:40:37Speaker 05

  Did you see the demo, the piano demo where you either you're there with a physical keyboard, or it could be a virtual keyboard, but the app basically highlights what keys you need to press in order to play the song. So it's basically like you're looking at your piano, and it's teaching you how to play a song that you choose.

• 1:41:00Andrew D. Huberman?

  An actual piano?

• 1:41:01Speaker 05

  Yeah.

• 1:41:01Andrew D. Huberman?

  Yeah, but it's illuminating certain keys in in the virtual space.

• 1:41:04Speaker 05

  Yeah. And it could either be a virtual piano if you or keyboard if you don't have a piano or keyboard, or it could use your actual keyboard. So, yeah, I think stuff like that is going to be really fascinating for education and expression.

• 1:41:22Andrew D. Huberman?

  And for broad, excuse me, but for and for broadening access to

• 1:41:25Speaker 05

  Totally.

• 1:41:25Andrew D. Huberman?

  expensive equipment. I mean, a piano is is no small expense.

• 1:41:29Speaker 05

  Exactly.

• 1:41:29Andrew D. Huberman?

  And it takes up a lot of space and it needs to be tuned.

• 1:41:32Speaker 05

  Yeah.

• 1:41:33Andrew D. Huberman?

  You can think of all these things, like the kid that has very little income or their family has very little income could learn to play a virtual piano at much lower cost.

• 1:41:40Speaker 05

  Yeah, it gets back to the question I was asking before about this thought experiment of how many of the things that we physically have today. Actually need to be physical. The piano doesn't. Maybe there's some premium where it's maybe it's a somewhat better, more tactile tactile experience to have a physical one. But for people who don't have the space for it, or who can't afford to buy a piano, or just aren't sure that they would want to make that investment at the beginning of learning how to play piano. I think in the future, you'll have the option of just buying, you know, an app or a hologram piano, which will be a lot more affordable. And I think it's gonna be, that's gonna be unlock unlock a ton of creativity too,

• 1:42:23Speaker 05

  because and instead of the market for piano makers being constrained to like a relatively small set of experts who have like perfected that craft, then you're gonna have like, you know, kids or developers all around the world designing crazy designs for potential keyboards and pianos that look nothing like what we've seen before, but are maybe like, bring even more joy and are even more kind of fun in the world where you have fewer of these physical constraints. So I don't know, I think it's gonna just, there's gonna be a lot of wild stuff to explore.

• 1:42:54Andrew D. Huberman?

  There's definitely gonna be a lot of wild stuff to explore. I was just had this, this idea slash image in my mind of what you were talking about merged with our earlier conversation when Priscilla was here of, you know, I could imagine a time not too far long from now where you're using mixed reality to run experiments in the lab, literally mixing virtual solutions, getting potential outcomes, and then picking the best one to then go actually do in the real world, which is very both financially costly and and time wise costly.

• 1:43:23Speaker 05

  Yeah, I mean, people are already using VR for surgery and education on it. And there's some study that was done that basically did, it tried to do a controlled experiment of people who learned how to do a specific surgery through just a normal kind of textbook and lecture method versus like, you show the knee and you have it, you know, be a large blown up model and people can manipulate it and kind of practice where they would make. The cuts and like the people in that class did better. So I think that there's, yeah, it's, I think it's going to be profound for a lot of different areas.

• 1:44:05Andrew D. Huberman?

  And the last example that leaps to mind, you know, I think that social media and online culture has been accused of creating a lot of real world, let's call it physical world, social anxiety for people. But I could imagine practicing a social interaction or a kid that has a lot of social anxiety or that needs to advocate for themselves better, learning how to do that progressively through a virtual interaction and then taking that to the real world because it's in my very recent experience today, it's so blended now with with real experience that the kid that feels terrified of advocating for themselves or or just talking to another human being or an adult or being in a new circumstance of a room full of kids, you could really experience that in in silicone first, get comfortable, let the nervous system attenuate a bit, and then take it into the quote unquote, physical world.

• 1:44:51Speaker 05

  Yeah, I think we'll see experiences like that. I mean, I also think that some of the social dynamics around how people interact in this kind of blended digital world will be more nuanced in other ways. So I'm sure that there will be kind of new anxieties that people develop too, just like, you know, teens today need to navigate dynamics around texting constantly that that we just didn't have when we were kids. So I think it will help with some things. I think that there will be new issues that hopefully we can help people work through too. But but overall, I think, yeah, no, I think it's going to be really powerful and positive.

• 1:45:29Andrew D. Huberman?

  Let's talk about the glasses.

• 1:45:30Speaker 05

  Sure.

• 1:45:31Andrew D. Huberman?

  This was wild.

• 1:45:32Speaker 05

  Yeah.

• 1:45:32Andrew D. Huberman?

  Put on a pair of Ray-Bans. I like the way they look. They're clear. They look like any other glass, Ray-Ban glasses, except that I could call out to the glasses. I could just say, you know, hey, Meta, I want to listen to the Bach variations, the Goldberg variations of Bach.

• 1:45:53Andrew D. Huberman?

  Meta responded and no one around me could hear, but I could hear with exquisite clarity. And by the way, I'm not getting paid to say any of this. I'm just still blown away by this, folks.

• 1:46:06Andrew D. Huberman?

  I want a pair of these very badly. I could hear, okay, I'm selecting those now and or that that music now. And then I could hear it in the background, but then I could still have a conversation. So this was neither headphones in nor headphones out. And I could say, wait, pause the music and it would pause. And the best part was I didn't have to leave the room mentally.

• 1:46:25Speaker 05

  Yeah.

• 1:46:25Andrew D. Huberman?

  I didn't even have to take out a phone.

• 1:46:27Speaker 05

  Yeah.

• 1:46:27Andrew D. Huberman?

  It was all interfaced through this very local environment in and around the head. And as a neuroscientist, I'm fascinated by this because of course, all of our perceptions, auditory, visual, etc. All occurring inside the casing of this of this thing we call a skull. But maybe you could comment on, you know, the the origin of that design for you, you know, what the ideas behind that? And where you think it could go, because I'm sure I'm just scratching the surface.

• 1:46:51Speaker 05

  The real product that we want to eventually get to is this kind of full augmented reality product in a kind of stylish and comfortable, normal glasses form factor.

• 1:47:03Andrew D. Huberman?

  Not dorky VR headset, so to speak.

• 1:47:05Speaker 05

  No, I mean.

• 1:47:05Andrew D. Huberman?

  Because the VR headset does feel kind of like.

• 1:47:07Speaker 05

  It will, but but there's.

• 1:47:08Andrew D. Huberman?

  Thing on the face.

• 1:47:08Speaker 05

  There's going to be a place for that, too, just like you have your laptop and you have your workstation. Or maybe the better analogy is you have your phone and you have your workstation. These AR glasses are going to be like your phone in that you have something on your face and you will, I think, be able to, if you want, wear it for a lot of the day and interact with with with it very frequently. I don't think that people are going to be, you know, walking around the world wearing VR headsets.

• 1:47:35Andrew D. Huberman?

  Let's hope not.

• 1:47:36Speaker 05

  But yeah, that's certainly not the future that I'm that I'm kind of hoping we get to. But I do think that there is a place where for having, you know, because it's a bigger form factor, it has more compute power. So just like your workstation or your your kind of bigger computer can do more than your phone can do. There's a place for that when you want to settle into an intense task, right? If you have a doctor who's doing a surgery, I would want them doing it through the headset, not through the kind of not through their phone equivalent or the the just kind of lower powered glasses. But just like phones are powerful enough to do a lot of things and the glasses will eventually get there, too.

• 1:48:12Speaker 05

  Now that said, there's a bunch of really hard technology problems to address in order to be able to get to this point where you can like put kind of full holograms in the world. You're basically miniaturizing a supercomputer and putting it into a pair of glasses so that the pair of glasses still looks stylish and normal. And that's a really hard technology problem. Making things small is really hard. A holographic display is, you know, it's different from what our industry has optimized for for 30 or 40 years now, building screens. There's like a whole kind of industrial process around

• 1:48:54Speaker 05

  that that goes into phones and TVs and computers and like increasingly so many things that that have different screens. Like, there's a whole pipeline that's gotten very good at making that kind of screen. And the holographic displays are just a completely different thing, right? Because it's not, it's not a screen, right? It's a thing that you can shoot light into through, you know, a laser or some other kind of projector and it can place that as an object in the world. So that's going to need to be this whole other industrial process that gets built up to doing that like in an efficient way. So, all that said, we're basically taking two different approaches towards building this

• 1:49:32Speaker 05

  at once. One is, we are trying to keep in mind, what is the the long term thing that it's not super far off. I think within, you know, a few years, I think we'll have something that that's sort of a first version of kind of this full vision that I'm talking about. And we have something that's working internally that we use as like a that we'll use as a dev kit. But that one, that's, that's kind of a big challenge. It's going to be more expensive. And it's harder to get all the pieces working. The other approach has been, all right, let's start with what we know we can put into a pair of stylish sunglasses today. And

• 1:50:15Speaker 05

  Just make them as smart as we can. So for the first version, we worked with, we did this collaboration with Ray-Ban, right? Because that's like, well-accepted. You know, these are well-designed glasses. They're classic. People have used them for decades. For the first version, we got a sensor on the front, so you could capture moments without having to take your phone out of your pocket. So you got photos and videos.

• 1:50:39Speaker 05

  You had the speaker and the microphone, so you can listen to music.

• 1:50:43Speaker 05

  You could communicate with it. But it was, you know, that was that was sort of the first version of it. We had a lot of the basics there, but we saw how people used it. And we tuned it. We made the camera is like twice as good for this new version that we made. The audio is a lot crisper for the use cases that we saw that people actually used, which is some of it is listening to music, but a lot of it is like, people want to take calls on their glasses. They want to listen to podcasts, right? But the biggest thing that I think is interesting is the ability to get AI running on it, which it doesn't just run on the on the glasses. It also it kind of proxies through your phone. But I mean, with all the advances in

• 1:51:26Speaker 05

  LLMs, we talked about this a bit in the first part of the conversation. Having the ability to have your meta AI assistant that you can just talk to and basically ask any question throughout the day is, I think, it'd be really fascinating. And, you know, like you were saying about kind of how we how we process the world as people.

• 1:51:47Speaker 05

  Eventually, I think you're going to want your AI assistant to be able to see what you see and hear what you hear. Maybe not all the time, but you're going to want to be able to tell it to go into a mode where it can see what you see and hear what you hear. And what's the kind of device design that best kind of positions an AI assistant to be able to see what you see and hear what you hear, so it can best help you? Well, that's glasses, right? Where or basically as a sensor to be able to see what you see and a microphone that is close to your ears that can hear what you hear.

• 1:52:22Speaker 05

  The other design goal is, like you said, to keep you present in the world, right? So I think one of the issues with phones is they kind of pull you away from, from what's physically happening around you. And I don't think that the next generation of computing will do that.

• 1:52:37Andrew D. Huberman?

  I just, I'm chuckling to myself because I have a friend, he's a very well-known photographer, and he was laughing about how, you know, people go to a concert and everyone's filming the concert on their phone so that they can be the person that posts the thing, but like there are literally millions of other people who posted the exact same thing. But somehow, our unique, it feels important to post our unique experience. With glasses, that would essentially smooth that gap completely.

• 1:53:01Speaker 05

  Yeah, totally.

• 1:53:02Andrew D. Huberman?

  You could just worry about it later, download it. There are issues I realize with, with glasses, because they are so seamless with everyday experience, even though you and I aren't wearing them now. It's very common for people to wear glasses. Issues of recording and consent.

• 1:53:16Speaker 05

  Yeah.

• 1:53:16Andrew D. Huberman?

  Like, I go into a locker room at my gym.

• 1:53:19Speaker 05

  That's where we have the light on.

• 1:53:19Andrew D. Huberman?

  I'm assuming that the people with glasses aren't filming. Whereas when, right now, because there's a, a sharp transition when, when there's a phone in the room and someone's pointing it, people generally say, no, no phones in locker rooms and recording. So that's just one instance. I mean, there are other instances.

• 1:53:35Speaker 05

  We have the whole privacy light. I don't know, did you, did you get a chance to do this?

• 1:53:38Andrew D. Huberman?

  I didn't get a chance to explore that.

• 1:53:39Speaker 05

  Yeah, so it's, anytime that it's active, that the camera sensor is active, it's, it's basically like pulsing a white, bright light.

• 1:53:48Andrew D. Huberman?

  Got it.

• 1:53:48Speaker 05

  So, which is, by the way, more than cameras do.

• 1:53:52Andrew D. Huberman?

  Right, someone would be holding a phone on the slide.

• 1:53:55Speaker 05

  Yeah, I mean, I mean, phones aren't, aren't kind of showing a light, a bright sensor when, when you're taking a photo, so.

• 1:54:00Andrew D. Huberman?

  No, people oftentimes will pretend they're texting and they're actually recording. I actually saw an instance of this in a barber shop once, where someone was recording and they were pretending that they were texting. And there was, there was a pretty intense interaction that ensued. And it was like, wow, you know, it's pretty easy for people to feign texting while actually recording.

• 1:54:19Speaker 05

  Yeah, so I think when you're evaluating.

• 1:54:23Speaker 05

  A risk with a new technology. The bar shouldn't be, is it possible to do anything bad? It's, does this new technology make it easier to do something bad than what people already had? And I think because you have this privacy light that is just broadcasting to everyone around you. Hey, this thing is recording now. Um, I think that that makes it actually less discreet to do it through the glasses than what you could do with a phone already. Um, which I think is, is basically the bar that we wanted to get over from a design perspective.

• 1:54:57Andrew D. Huberman?

  Thank you for pointing out that it has the privacy light. I didn't get long enough in the experience to explore all the features. But, um, again, I can think of a lot of uses. Um, being able to look at a restaurant from the outside and see the menu.

• 1:55:10Speaker 05

  Oh, yeah.

• 1:55:11Andrew D. Huberman?

  Get status on how crowded it is. Um, as much as I love, uh, I don't want to call out, uh, let's just say, um, app-based map, uh, functions that allow you to navigate. And the audio is okay. It's nice to have a conversation, um, with somebody on the phone or in the vehicle. And just, it'd be great if the road was traced where I should turn.

• 1:55:30Speaker 05

  Yeah, absolutely.

• 1:55:31Andrew D. Huberman?

  These kinds of things seem like it's going to be straightforward for, for meta engineers to create.

• 1:55:36Speaker 05

  Future version, we'll have it, so it'll also have the holographic display where it can show you the directions. But I, I think that there will just basically just be, you know, different price points that pack different amounts of technology. The holographic display part, I think is going to be more expensive than doing one that just has the AI. But is, um, but is primarily communicating you with, with you through audio. So, I mean, the, the current Ray-Ban Meta Glasses are $2.99. Um, you know, I think when we have one that has a display in it, it'll probably be some amount more than that, but it'll also be more powerful. So I think that, that it'll, people will choose what they want to use based on what the capabilities are that they want and what they can afford. But, um, but a lot of our goal in building things is, um,

• 1:56:23Speaker 05

  You know, we try to make things that can be accessible to everyone. You know, our game as a company isn't to build things and then charge a premium price for it. We try to build things that then everyone can use and then become more useful because a very large number of people are using them. So it's just a very different approach. You know, we're not, we're not like Apple or some of these companies that just try to make something and then sell it for as much as they can, which I mean, they're a great company. So I mean, I think that that, that model kind of is, is fine too. But, um, but our approach is going to be, we want stuff that can be affordable so that way everyone in the world can use it.

• 1:57:04Andrew D. Huberman?

  Long lines of health, I think the glasses will also potentially solve a major problem in a, in a real way, which is the following, for both children and adults, it's very clear that viewing objects in particular screens up close for too many hours per day leads to myopia. Literally a change in the length, length of the eyeball and nearsightedness.

• 1:57:23Speaker 05

  Yep.

• 1:57:24Andrew D. Huberman?

  And on the positive side, we know, based on some really large clinical trials, that kids who spend and adults who spend two hours a day or more out of doors, um, don't experience that and maybe even reverse their myopia. And it has something to do with exposure to sunlight, but it has a lot to do with long viewing, viewing things at a distance greater than three or four feet away. And with the glasses, I realize one could actually do digital work out of doors. It could measure and tell you how much time you've spent looking at things up close versus far away. I mean, this is, this is just another example that leaps to mind, but in, in accessing the visual system, you're effectively accessing the whole brain because it's the only two bits of brain that are outside the cranial vault.

• 1:58:07Andrew D. Huberman?

  So it just seems like putting technology right at the level of the eyes, seeing what the eyes see is just gotta be the best way to go.

• 1:58:15Speaker 05

  Yeah, I think, well, multimodal, right? I, I think is you want the visual. Sensation, but you also want kind of text or language. So

• 1:58:26Andrew D. Huberman?

  Sure.

• 1:58:26Speaker 05

  I think it's

• 1:58:27Andrew D. Huberman?

  But that all can be brought to the level of the eyes, right?

• 1:58:30Speaker 05

  What do you mean by that?

• 1:58:31Andrew D. Huberman?

  Well, I mean, I think what we're describing here is essentially taking the phone, the computer, and bringing it all to the level of the eyes. And of course, one would like more

• 1:58:40Speaker 05

  Physically at your face.

• 1:58:40Andrew D. Huberman?

  Physically at your eyes, right?

• 1:58:41Speaker 05

  Yeah.

• 1:58:42Andrew D. Huberman?

  And one would like more kinesthetic information, as you mentioned, for where the legs are, maybe even lung function. Hey, have you taken enough steps today? But that all can be, if it can be figured out on the phone, it can be by the phone. It can be figured out by glasses. But there's additional information there, such as what are you focusing on in your world? How much of your time is spent looking at things far away versus up close? How much social time did you have today? It's really tricky to get that with a phone, like, like if my phone were right in front of us as if we were at a standard lunch nowadays, certainly in Silicon Valley, and then people were peering at our phones. I mean, how much real, direct attention was in the conversation at hand versus something else? I mean, you can get issues of where are you placing your attention? By virtue of where you're placing your eyes. And I think that information is not accessible with a phone in your pocket or in front of you.

• 1:59:27Speaker 05

  Yeah.

• 1:59:27Andrew D. Huberman?

  I mean, a little bit, but not nearly as rich and complete information as one gets when you're really pulling the data from the level of of vision and what what kids and adults are actually looking at and attending to.

• 1:59:39Speaker 05

  Yeah, yeah.

• 1:59:40Andrew D. Huberman?

  It seems extremely valuable. You get autonomic information, size of the pupils. So you get information about internal states. I mean, that you can't

• 1:59:48Speaker 05

  There's internal sensor and outside. So there's the sensor on the Ray-Ban Meta glasses is external, right? So it's basically allows you to see what you see. Then it allows, sorry, the AI assistant to see what you're seeing. There's a separate set of things which are eye tracking, which are also very powerful for enabling a lot of interfaces, right? So you want to, if you want to just like look at something and select it by looking at it with your eyes, rather than having to kind of drag a controller over or pick up a hologram or anything like that. You can do that with eye tracking. So that's a pretty profound and cool experience, too,

• 2:00:31Speaker 05

  as well as just kind of understanding what you're looking at so that way you're not kind of wasting compute power, drawing pixels in high resolution in a part of the kind of world that you're not, that's going to be in your peripheral vision.

• 2:00:43Speaker 05

  So, yeah, all of these things.

• 2:00:47Speaker 05

  There are interesting design and technology trade offs where if you want the external sensor, that's one thing. If you also want the eye tracking, now that's a different set of sensors. Each one of these consumes compute, which consumes battery. They take up more space. Right. So it's like, where are the eye tracking sensors going to be? It's like, well, you want to make sure that the rim of the glasses is actually quite thin. Because, I mean, it's, you know, there's a kind of variance of, you know, how thick can glasses be before they look more like goggles than glasses? I think that this is, there was this whole space and I think people are going to end up choosing what product makes sense for them. Maybe they want something that's more powerful, that has more of the sensors, but it's, but it's going to be a little more expensive,

• 2:01:30Speaker 05

  maybe like slightly thicker, or maybe you want like a more basic thing that just looks like very similar to what Ray-Ban glasses are that people have been wearing for decades, but kind of has AI in it and you can capture moments without having to take your phone out and send them to people. In the latest version, we've got the ability into live stream. I think that that's pretty crazy that now you can be kind of going back to your concert case or whatever else you're doing, you know, you can be doing sports and just, you know, or watching your kids play something and just, you can be watching and you can be live streaming it to your, your kind of family group. So people can see it. I think that like, that stuff is,

• 2:02:13Speaker 05

  I, I think that's pretty cool that you basically have a normal looking pair of glasses at this point that can kind of live stream and has like an AI assistant. So the stuff is making a lot faster progress in a lot of ways than I would have thought. And I don't know, I think people are going to like this version, but there's a lot more still to do.

• 2:02:31Andrew D. Huberman?

  I think it's super exciting and I see a lot of technologies. This one's particularly exciting to me because of how smooth the interface is and for all the reasons that you just mentioned. What's happening with and what can we expect around AI interfaces and maybe even avatars of people within social media? Are we not far off from a day where there are multiple versions of me and you on the internet where people, for instance, I get asked a lot of questions. I don't have the opportunity to respond to all those questions, but with things like ChatGPT, people are trying to generate answers to those questions on other platforms. Will I have the opportunity to soon have an AI version of myself where people can ask me questions about like what I recommend for sleep and circadian rhythm, fitness,

• 2:03:14Andrew D. Huberman?

  mental health, et cetera, based on content I've already generated that will be accurate? So they could just ask my avatar?

• 2:03:20Speaker 05

  Yeah, this is something that I think a lot of creators are gonna want that that we're trying to build. And I think we'll probably have a version of next year. But there's a bunch of constraints that I think we need to make sure that we get right. So for one, I think it's really important that it's not that there's a bunch of versions of you. It's that if anyone is creating like an AI assistant version of you, it should be something that you control, right? It's I think there are some platforms that are out there today that just let people like make, I don't know, the AI bot of me or other

• 2:03:59Speaker 05

  figures. And it's like, I don't know. I mean, we we have platform policies for for like decades, like, you know, since the beginning of the company at this point, which is almost 20 years, that that basically don't allow impersonation. You know, real identity is like one of the core aspects that that kind of our company was was started on is like you want to authentically be yourself. So yeah, I think if you're if you're almost any creator, being able to engage your community, and there's just going to be more demand to interact with you than you have hours in the day. So there are both people who

• 2:04:40Speaker 05

  out there who would benefit from being able to talk to an AI version of you. And I think you and other creators would benefit from being able to keep your community engaged and service that demand that people have to engage with you. But you're going to want to know that that AI kind of version of you or assistant is going to represent you the way that you would want. And there are a lot of things that are awesome about kind of these modern LLMs. But

• 2:05:09Speaker 05

  Having perfect predictability about how it's going to represent something is not one of the current strengths. So I think that there's some work that needs to get done there. I don't think it needs to be 100% perfect all of the time, but you need to have very good confidence, I would say, that it's gonna, that's gonna represent you the way that you'd want for you to want to turn it on, which again, you should have control over whether you turn it on. So we wanted to start in a different place, which I think is a somewhat easier problem, which is creating new characters that the, for AI personas. So that way, it's not, you know, we built, you know, one of the AIs is like a chef, and they can help you kind of come up with things that you should, that you

• 2:05:54Speaker 05

  could cook and can help you cook them. There's like, a couple of people that are interested in different types of fitness that can help you kind of plan out your workouts, or help with recovery, or different things like that. There are people, there's an AI that's focused on like DIY crafts. There's someone who's a travel expert that can help you make travel plans or give you ideas. So, but the key thing about all these is they're not, they're not modeled off of existing people. So they don't have to have kind of 100% fidelity to like, making sure that they never say something that, you know, a real person who they're modeled after would never say because they're just made up characters. So I think

• 2:06:36Speaker 05

  that that is, that's a somewhat easier problem. We actually got the, we got a bunch of different kind of well-known people to play those characters because we thought that would make it more fun. So there's like Snoop Dogg is the dungeon master. So you can like drop him into a thread and play text-based games. And it's just like, I do this with my daughter when I, when I tuck her in at night and she just like loves it, like. Like storytelling, right? And it's like, it's like Snoop Dogg is the dungeon master will come up with like, here's what's happening next. And she's like, okay, like turn into a mermaid and then I like swim across the bay and I go and find the the treasure chest and unlock it. And it's like, and then Snoop Dogg just always will have a next version of the like the next iteration on the story. So I mean,

• 2:07:20Speaker 05

  it's stuff is fun, but you know, it's not actually Snoop Dogg. He's just kind of the actor. He's playing the dungeon master, which makes it more fun. So I think that's probably the right place to start is you have like, you can kind of build versions of these characters that that people can interact with doing different things. But I think where you want to get over time is to the place where any creator or any small business can very easily just create an AI assistant that can represent them and interact with your kind of community or customers, if you're a business, and basically just help you grow your your enterprise. So I don't know, I think that's gonna be cool. But I think this is it's a long term project. I think we'll have more progress on

• 2:08:04Speaker 05

  it to report on next year. But but I think that's coming.

• 2:08:10Andrew D. Huberman?

  I'm super excited about because of, you know, we hear a lot about the downsides of AI. I mean, I think people are now coming around to the reality that AI is neither good nor bad. It can be used for good or bad, and that there are a lot of life enhancing spaces that it's going to show up and really, really improve the way that we engage socially, what we learn, and that mental health and physical health don't have to suffer and in fact can be enhanced by the sorts of technologies we've been talking about. So I know you're extremely busy. I so appreciate the large amount of time you've given me today to sort through all these things.

• 2:08:44Speaker 05

  It's been fun.

• 2:08:44Andrew D. Huberman?

  And to talk with you and Priscilla and to hear what's happening and where things are headed. The future certainly is bright. I share in your optimism and it's been only strengthened by today's conversation. So thank you so much and keep doing what you're doing. And on behalf of myself and everyone listening, thank you, because regardless of what people say, we all use these platforms excitedly, and it's clear that there's a ton of intention and care and and thought about, you know, what could be in the positive sense. And and that's really worth highlighting.

• 2:09:21Speaker 05

  Awesome. Thank you. I appreciate it.

• 2:09:24Andrew D. Huberman?

  Thank you for joining me for today's discussion with Mark Zuckerberg and Dr. Priscilla Chan. If you're learning from and/or enjoying this podcast, please subscribe to our YouTube channel. That's a terrific, zero-cost way to support us. In addition, please subscribe to the podcast on both Spotify and Apple. And on both Spotify and Apple, you can leave us up to a five-star review. Please also check out the sponsors mentioned at the beginning and throughout today's episode. That's the best way to support this podcast. If you have questions for me or comments about the podcast, or guests that you'd like me to consider hosting on the Huberman Lab podcast, please put those in the comment section on YouTube. I do read all the comments. Not during today's episode, but on many previous episodes of the Huberman Lab podcast, we discuss supplements. While supplements aren't necessary for everybody, many people derive tremendous benefit from them, for things

• 2:10:09Andrew D. Huberman?

  like enhancing sleep, hormone support, and improving focus. If you'd like to learn more about the supplements discussed on the Huberman Lab podcast, you can go to Live Momentous, spelled O-U-S, so livemomentous.com/huberman. If you're not already following me on social media, it's Huberman Lab on all social media platforms. That's Instagram, Twitter, now called X, Threads, Facebook, LinkedIn, and on all those places, I discuss science and science-related tools, some of which overlaps with the content of the Huberman Lab podcast, but much of which is distinct from the content on the Huberman Lab podcast. So again, it's Huberman Lab on all social media platforms. If you haven't already subscribed to our monthly Neural Network newsletter, the Neural Network newsletter is a completely zero-cost newsletter that gives you podcast summaries, as well as toolkits in the form of brief

• 2:10:54Andrew D. Huberman?

  PDFs. We've had toolkits related to optimizing sleep, to regulating dopamine, deliberate cold exposure, fitness, mental health, learning and neuroplasticity, and much more. Again, it's completely zero cost to sign up. You simply go to hubermanlab.com, go over to the menu tab, scroll down to newsletter, and supply your email. I should emphasize that we do not share your email with anybody. Thank you once again for joining me for today's discussion with Mark Zuckerberg and Dr. Priscilla Chan. And last, but certainly not least, thank you for your interest in science.